LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) has been selected by the Illinois Department of Healthcare and Family Services (HFS) to serve members statewide in HealthChoice Illinois, the state’s Medicaid managed care program. Humana looks forward to supporting Illinois’ goals for health and well-being of the individuals and families it will serve.
For more than a decade, Humana has had the privilege of serving some of Illinois’ most vulnerable residents, caring for dual eligible members who navigate both Medicare and Medicaid through the Medicare-Medicaid Alignment Initiative (MMAI), and, today, the state’s Fully Integrated Dual Eligible Special Needs Plan (FIDE-SNP) which launched January 1, 2026. HealthChoice Illinois is an opportunity for Humana to extend that same commitment to more individuals and families the state serves, across 102 counties, in continued partnership with HFS.
“It’s an honor to care for more Illinois Medicaid members and their families,” said Samantha Olds Frey, Humana’s Medicaid President in Illinois. “Our goal has always been to provide whole-person care across every generation, from children to older adults, and HealthChoice Illinois lets us do that. We’re grateful for the confidence HFS has placed in us, and we’ll keep working alongside the state, providers and community organizations to improve care and quality of life for the communities who depend on us.”
Humana’s approach reflects HFS’s priorities and commitment to whole-person care. As an active member of the community, Humana has invested in local organizations that address the health-related social needs of Illinois Medicaid members, including maternal health, behavioral health and housing stability:
Maternal Health: Humana is partnering with the Illinois Public Health Association to ease maternal health workforce shortages in high-disparity counties and expand the availability of community health workers to support enrollees. Behavioral Health: Through collaboration with Southern Illinois University’s Behavioral Health Workforce Center, Humana will help increase workforce capacity in rural and underserved areas. Additionally, Humana is working with Brightpoint to support the Schubert Family Wellness Center in Chicago’s Belmont Cragin neighborhood. Supportive Housing: Mercy Housing Lakefront, one of the nation’s largest nonprofit affordable housing providers, and Humana are working together to provide transitional housing support and help prevent homelessness among members. Humana’s HealthChoice plan is slated to go live in January 2027 and looks forward to continuing its partnership with the state of Illinois to deliver meaningful, member-centered care and drive improved health outcomes for years to come.
About Humana
Humana (NYSE:HUM) is a leading U.S. healthcare company. Through our Humana insurance services and our CenterWell® healthcare services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare and Medicaid, families, individuals, military service personnel, and communities at large. Learn more about what we offer at Humana.com and at CenterWell.com.
@Theotrade's Don Kaufman walks us through today's Big 3 and offers example options trades for his picks. He points to Humana (HUM) as a great bearish opportunity in the weeks to come, Bank of America (BAC) as a bullish opportunity into all-time high territory, and Microsoft (MSFT) not being able to shake bearish trends.
Until recently, it had been a lackluster year for the healthcare sector. From high medical utilization squeezing insurers to structural cost pressures and valuation hangovers, medical stocks stocks have lagged much of the broader market this year. But there are some indications that the tide is turning.
The market’s increasingly concentrated tech focus continues to encourage the rotation into overlooked, defensive sectors like healthcare. At the same time, costs are beginning to stabilize, and the U.S. Food and Drug Administration (FDA) has been supportive of the biopharma pipeline, meeting review deadlines and accelerating pathways for novel therapies.
Get Eli Lilly and Company alerts:
Over the past month, healthcare’s 5.4% gain only trails financials (at 6.36%) and tech (at 5.78%). While that broad turnaround has been welcomed by investors looking for a spark from the sector, the outsized performances of three stocks in particular have played a big role in the rally.
Eli Lilly: The Market Cap King of Pharma Continues Its GLP-1 DominanceEli Lilly and Company Stock Forecast Today12-Month Stock Price Forecast:
$1,227.74
11.74% Upside
Moderate Buy
Based on 30 Analyst Ratings
Current Price$1,098.78High Forecast$1,400.00Average Forecast$1,227.74Low Forecast$850.00Eli Lilly and Company Stock Forecast Details
Big Pharma member Eli Lilly NYSE: LLY boasts the largest market cap by far of any healthcare company. At about $1 trillion, Eli Lilly is nearly double that of Johnson & Johnson NYSE: JNJ, whose $562 billion market cap ranks second.
So when LLY outperforms, it has the ability to impact the broader sector as a whole.
Over the past month, shares are up around 11%, continuing a rally that’s seen the stock rise nearly 31% from its year-to-date (YTD) low on April 29. There are numerous catalysts driving Eli Lilly’s performance of late, but principally, the surge boils down to hypergrowth of its GLP-1 metabolic drug line.
The pharmaceutical company’s two flagship GLP-1 drugs, Mounjaro and Zepbound, continue to dominate the global market. In Q1 2026, sales of Mounjaro—which is most often prescribed to treat Type 2 diabetes—jumped 125% year over year (YOY) to nearly $8.7 billion. Zepound added more than $4 billion in sales, good for a YOY increase of around 80%.
On April 1, Eli Lilly received FDA approval for its oral GLP-1 pill, Foundayo. Because Foundayo is a pill and doesn't require strict food and water fasting restrictions like older oral biologics, it vastly expands Eli Lilly’s total addressable market for individuals who are looking to avoid injectable therapeutics.
So it was no surprise when the company blew past earnings expectations in Q1, with earnings per share (EPS) of $8.55 easily surpassing analyst expectations of $6.97, and revenue of $19.8 billion coming in higher than the forecasted $17.82 billion and 56% higher YOY.
But with a forward price-to-earnings (P/E) multiple of around 31, critics contend that LLY is trading at tech stock valuations rather than a defensive healthcare position.
Nonetheless, as the sector’s largest player, 25 of the 30 analysts currently covering Eli Lilly assign it a Buy or Strong Buy, with the stock receiving a consensus Moderate Buy rating. Meanwhile, the average 12-month price target for LLY implies approximately 10% additional upside.
Current Price$360.84High Forecast$441.00Average Forecast$291.35Low Forecast$195.00Humana Stock Forecast Details
Louisville-based insurance provider Humana NYSE: HUM has been one of the market’s biggest comeback stories in 2026.
At the end of Q1, the stock was down more than 70% from its all-time high in 2022.
That was mostly driven by a post-pandemic rush of medical treatment that saw Humana’s benefit ratio—the percentage of premiums spent on actual medical care—climb to an unsustainable 93% by the end of 2025.
But after hitting its five-year low on March 12, the stock has gained nearly 123%, including more than 18% over the past month.
After years of facing staggeringly high benefit ratios, Humana has seen elective treatments moderate, which in turn has widened the company’s margins. In Q1, net income margin stood at 2.99% versus negative 2.39% in Q4 2025 and 0.59% in Q3 2025.
Analysts were also impressed with Humana’s revenue growth, which in Q1 registered 23.47% after averaging just 10.17% over the preceding five quarters. Of the 28 analysts covering Humana, only nine have assigned it a Buy or Strong Buy rating. Overall, it receives a consensus Hold rating and an average 12-month price target that suggests a notable correction could be in the cards after HUM’s share price has run up in recent months.
Current Price$72.47High Forecast$102.00Average Forecast$84.83Low Forecast$64.00DexCom Stock Forecast Details
With a market cap of nearly $28 billion, DexCom NASDAQ: DXCM is the least recognizable stock on this list.
The company develops, manufactures, and distributes medical devices, including continuous glucose monitoring (CGM) systems for people with diabetes.
Its products are designed to provide near-real-time glucose readings, trend data, and alerts to help patients and clinicians manage insulin dosing and reduce the risk of hypoglycemia and hyperglycemia.
The stock had fallen on tough times, down nearly 55% from its all-time high in November 2021. But DexCom changed the narrative with a massive expansion into the non-insulin market.
Historically, CGMs were primarily targeted to intensive insulin users. But the company is aggressively moving into the broader Type 2 diabetes and preventative health markets.
At an American Diabetes Association conference in June, DexCom released landmark data from its CONNECT trial demonstrating that its flagship G7 sensor led to statistically significant reductions in blood sugar levels for adults with Type 2 diabetes who do not use insulin. At the same time, the company released a revamped app for Stelo, the first over-the-counter CGM designed specifically for pre-diabetics and Type 2 diabetics not on insulin, thereby opening up a massive new addressable market for the company.
DXCM is now up more than 27% since its YTD low on April 29, including a gain of more than 15% over the past month. DexCom has beat on EPS for four consecutive quarters, with revenue growth averaging 15.61% over that time versus the 1.97% growth it saw preceding that stretch.
Despite the recent run-up, analysts forecast nearly 19% additional upside over the next 12 months to go along with a consensus Moderate Buy rating.
Should You Invest $1,000 in Eli Lilly and Company Right Now?Before you consider Eli Lilly and Company, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eli Lilly and Company wasn't on the list.
While Eli Lilly and Company currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.
Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.
Key Takeaways DK and MPC are both refining players, but they offer a different blend of scale and operational strategy.Marathon Petroleum is expanding jet fuel, LPG and MPLX projects to support long-term growth.DK's improving operational performance create opportunities, but regulatory and market risks remain. Delek US Holdings, Inc. (DK - Free Report) and Marathon Petroleum Corporation (MPC - Free Report) represent two distinct investment opportunities within the Oil and Gas - Refining and Marketing industry, each offering a different blend of scale, growth potential and operational strategy. While both companies are involved in refining, transportation and marketing of petroleum products, the similarities largely end there. Marathon Petroleum is the largest independent refiner in the United States, backed by an expansive refining footprint and substantial midstream assets that provide scale and stability. Delek, on the other hand, operates on a much smaller scale but has attracted attention through targeted efficiency initiatives and operational improvements aimed at enhancing profitability.
For investors evaluating exposure to the downstream energy space, understanding how Delek and Marathon Petroleum compare in terms of business strength, growth prospects, financial performance and shareholder returns is essential. Let’s examine the strengths, challenges and investment appeal of both companies to determine which stock may be better suited for investors today.
The Case for Delek StockDelek entered 2026 with improving operational performance and growing cash flow potential. Its strengths in refining and logistics create opportunities, though regulatory and market risks remain key challenges.
Delek’s strong operational momentum was highlighted by the successful completion of the Big Spring refinery turnaround, which was executed on time and within budget and is expected to enhance reliability, boost product yields and increase margin capture. Another key differentiator is the company’s Enterprise Optimization Plan (EOP), whose annual run-rate target was raised for the sixth consecutive time to at least $220 million. The initiative has already generated meaningful earnings improvements through stronger margins, lower costs and enhanced logistics performance. In addition, Delek has one of the highest diesel and jet fuel yields among its peers and enjoys direct access to multiple domestic crude sources through its integrated logistics network, providing a competitive advantage in volatile market conditions. The company’s midstream segment, Delek Logistics (DKL), also helps to diversify earnings and support shareholder returns.
In the near past, the global supply disruptions and elevated product prices also supported Delek’s refining margins as it has strong crude access and distillate yields. With no major turnarounds planned for the remainder of 2026, the company is positioned to maximize free cash flow generation and capitalize on stronger seasonal demand. Growth projects in the Permian Basin, including sour gas gathering and acid gas injection infrastructure, provide additional long-term expansion opportunities. Furthermore, Delek’s ongoing deconsolidation and value-unlocking initiatives could help narrow the gap between intrinsic asset value and market valuation.
Despite these positives, Delek remains exposed to refining margin volatility, fluctuating crude and product prices, and broader macroeconomic conditions. Regulatory uncertainty surrounding Renewable Fuel Standard (RFS) compliance and Small Refinery Exemptions (SREs) could significantly impact profitability. Delek also faces operational risks from weather disruptions, maintenance activities and changes in fuel demand, making continued execution of its optimization strategy critical to sustaining performance.
The Case for Marathon Petroleum StockMarathon Petroleum’s strengths are rooted in its integrated business model, strong cash generation, operational excellence and strategic investments that support long-term growth and shareholder value creation.
In the first quarter, Marathon Petroleum generated $1.7 billion in operating cash flow excluding working capital and delivered strong results despite completing 40% of its planned annual turnaround activity. Its refining system operated at 89% utilization, reflecting strong operational execution, commercial optimization and effective management of market volatility. These capabilities enabled MPC to capitalize on favorable refining margins and maintain profitability across key operating regions.
A key differentiator of the company is the stability provided by its midstream subsidiary, MPLX. The business continues to generate substantial and predictable cash flows, reducing earnings volatility and strengthening MPC’s through-cycle performance. Management expects MPLX distributions to cover MPC’s standalone capital spending and dividend requirements, creating additional flexibility for shareholder returns. The company reinforced this commitment by returning more than $1 billion to shareholders during the quarter and authorizing an additional $5 billion share repurchase program. This disciplined capital-return strategy highlights management’s confidence in the durability of future cash flows and the resilience of the business model.
MPC has several promising growth opportunities driven by strategic investments across its refining and midstream businesses. The company is expanding jet fuel production capacity through projects at Garyville, El Paso and Robinson, positioning itself to benefit from rising demand for jet fuel and specialty products while improving profitability. MPC is also growing its international LPG trading presence and securing long-term demand commitments linked to future MPLX fractionation projects. Additionally, MPLX’s $2.4 billion growth program — focused on natural gas, NGL processing, fractionation and export infrastructure — is expected to capitalize on increasing LNG exports, power generation needs and industrial demand. These investments should enhance cash flow stability, support distribution growth and strengthen MPC’s long-term value creation potential.
Price PerformanceIn the past three months, shares of MPC and DK have gained 7.4% and 3.9%, respectively.
Image Source: Zacks Investment Research
Valuation ComparisonFrom a valuation perspective — in terms of forward price-to-sales ratio — Delek is trading at a discount of 0.26X compared with Marathon Petroleum’s 0.53X.
Image Source: Zacks Investment Research
EPS RevisionsThe Zacks Consensus Estimate for Delek’s 2026 earnings has been revised about 15.9% upward over the past 30 days.
Image Source: Zacks Investment Research
However, the Zacks Consensus Estimate for Marathon Petroleum’s 2026 earnings has been revised about 8.4% upward during the same time period.
Image Source: Zacks Investment Research
ConclusionWhile both companies present compelling investment cases, Marathon Petroleum emerges as the better-positioned investment due to its superior scale, stronger cash-generation capabilities and more diversified business model.
While Delek has made meaningful progress through operational optimization, refinery improvements and value-unlocking initiatives, its performance remains more exposed to refining margin volatility and regulatory uncertainty, justifying its Zacks Rank #3 (Hold).
In contrast, Marathon Petroleum benefits from a large, integrated refining network and the stable cash flows generated by MPLX, which provide resilience across market cycles, supporting its Zacks Rank #1 (Strong Buy). Its ability to consistently return capital through dividends and share repurchases, combined with strategic investments in jet fuel, LPG trading and midstream infrastructure, supports long-term growth and cash flow stability.
Combined with superior stock price performance, Marathon Petroleum stands out as a more compelling choice for investors seeking sustainable value creation and lower risk exposure.
You can see the complete list of today’s Zacks #1 Rank stocks here.
Converging forces are pushing rates higher in 2026. The Iran conflict closed the Strait of Hormuz, spiking crude oil prices and raising production and transport costs. This energy shock drove inflation higher, with the Consumer Price Index rising 3.8%, which was the sharpest increase in three years and well above the Federal Reserve’s 2% target. This, in turn, has prompted lenders to demand higher rates to protect returns. Meanwhile, investors sold bonds amid rising inflation and concerns about U.S. debt, lifting Treasury yields. Since mortgage rates are based on the 10-year Treasury yield plus a risk premium, they rose in tandem. On the fiscal side, federal interest payments now exceed spending on Medicaid, national defense, and all nondefense discretionary programs combined, adding further upward pressure on long-term borrowing costs. Experts say rates will only fall if geopolitical tensions ease, oil prices stabilize, and inflation remains under control, outcomes that remain uncertain at best.
Typically, when interest rates go higher, these four sectors tend to win:
Financials Energy Healthcare Industrials We screened our 24/7 Wall St. dividend stocks database for quality companies that pay big, dependable dividends and generate reliable passive income. We found four companies, one in each sector, that are solid bets if the upward trend in interest rates remains in place. All are rated Buy by the top Wall Street firms we cover.
Financials Financials are the biggest winner. Banks earn a wider spread between what they pay depositors and what they charge borrowers. Insurers earn more on their investment portfolios. The sector almost mechanically benefits from rising rates, as net interest income rises.
U.S. Bancorp Based in Minneapolis, this super-regional financial giant is an outstanding choice for growth and income investors now, offering a hefty 3.56% dividend. U.S. Bancorp (NYSE: USB | USB Price Prediction) is a financial services holding company.
The bank’s segments are:
Wealth Corporate Commercial and Institutional Banking Consumer and Business Banking Payment Services Treasury and Corporate Support It offers a comprehensive range of financial services, including lending and deposit services, cash management, capital markets, and trust and investment management services. It also engages in credit card services, merchant and ATM processing, mortgage banking, insurance, brokerage, and leasing.
The company’s banking subsidiary, U.S. Bank National Association (USBNA), is engaged in the banking business, principally in domestic markets. USBNA provides a range of products and services to individuals, businesses, institutional organizations, governmental entities, and other financial institutions.
The non-banking subsidiaries offer investment and insurance products to customers primarily within their domestic markets, as well as fund administration services to a range of mutual and other funds.
Oppenheimer has assigned an Outperform rating with a target price of $74.
Energy Energy benefits because rate hikes typically coincide with inflation, and oil/gas prices are a primary driver of inflation. Higher commodity prices translate to higher revenues. It is the inflation-hedge play and has been the strongest-performing S&P sector so far in 2026.
Enterprise Products Partners This top American midstream natural gas and crude oil pipeline company is headquartered in Houston, Texas. Enterprise Products Partners (NYSE: EPD) is one of the most extensive publicly traded energy partnerships and pays a reliable 5.88% dividend. The company’s debt-to-EBITDA ratio ranges from 3.1x to 3.4x, which is moderate for a midstream energy company, and its interest coverage ratio is 5x.
Enterprise Products Partners generates strong free cash flow, with an operating cash flow of approximately $8.8 billion, resulting in approximately $4.2 billion in free cash flow annually after deducting capital expenditures. Another significant benefit for shareholders is that most of the corporate debt is fixed-rate, thereby limiting the risk of rising interest rates.
Enterprise Products Partners provides various midstream energy services, including:
Gathering, processing, transporting, and storing natural gas, natural gas liquids (NGL), and fractionation Import and export terminalling Offshore production platform services The company has four reportable business segments:
Natural Gas Pipelines and Services NGL Pipelines and Services Petrochemical Services Crude Oil Pipelines and Services One reason many analysts like the stock might be its distribution coverage ratio. The company’s coverage ratio is well above 1x, making it relatively less risky among the master limited partnerships.
Citigroup has a Buy rating with a $44 target price.
Healthcare Pricing power and steady demand insulate the top healthcare names. They don’t directly benefit from higher rates, but they tend to hold up well because their earnings don’t erode as much as those of interest-sensitive sectors.
Bristol-Myers Squibb Bristol-Myers Squibb (NYSE: BMY) is a global biopharmaceutical company discovering, developing, and delivering innovative medicines for patients with serious diseases across oncology, hematology, immunology, cardiovascular disease, neuroscience, and other therapeutic areas. It remains a solid pharmaceutical stock to own in the long term, offering an outstanding entry point with a reliable 4.45% dividend.
The company’s platforms comprise chemically synthesized or small-molecule drugs, including protein degraders, as well as biologics produced through biological processes. These platforms also encompass ADCs, CAR-T cell therapies, and radiopharmaceutical therapeutics.
Small-molecule drugs are typically administered orally in tablet or capsule form, although other drug-delivery mechanisms are also used. Biologics are usually administered by injection or intravenous infusion. CAR-T cell therapies are administered by intravenous infusion.
Eliquis Revlimid Pomalyst/Imnovid Sprycel Abraxane Bank of America has a Buy rating with a $67 target price.
Industrials Industrial stocks often perform well in rising-rate environments because rate hikes can signal a strengthening and expanding economy. As businesses ramp up activity, demand for heavy equipment, machinery, and manufacturing capacity increases. This allows these cyclical companies to secure stronger order books and exercise greater pricing power, more than enough to offset their higher cost of capital.
Stanley Black & Decker Stanley Black & Decker (NYSE: SWK) is the world’s largest tool company, with 50 manufacturing facilities in the United States and more than 100 worldwide. It trades at 13.54 times forward earnings estimates. With the potential for the economy to slow somewhat, you can bet that the do-it-yourself legions will fix rather than buy new, and this legendary stock is a solid idea now, while yielding a large 3.96% dividend.
Stanley Black & Decker provides hand tools, power tools, outdoor products, and related accessories in the United States, Canada, the Other Americas, Europe, and Asia. Its Tools & Outdoor segment offers professional-grade corded and cordless electric power tools and equipment, including:
Drills Impact wrenches and drivers Grinders, saws, routers, and sanders Pneumatic tools and fasteners, such as nail guns, nails, staplers and staples, and concrete and masonry anchors; corded and cordless electric power tools Hand-held vacuums, paint tools, and cleaning appliances Leveling and layout tools, planes, hammers, demolition tools, clamps, vises, knives, saws, chisels, and industrial and automotive tools Drill bits, screwdriver bits, router bits, abrasives, saw blades, and threading products Toolboxes, sawhorses, storage cabinets, and engineered storage solutions Electric and gas-powered lawn and garden products This segment sells its products under such brand names as:
DeWalt Craftsman Black+Decker Stanley Flex Volt Irwin Lenox The company’s Industrial segment provides:
Threaded fasteners, blind rivets and tools, blind inserts and tools Drawn arc weld studs and systems Engineered plastic and mechanical fasteners Self-piercing riveting systems Precision nut running systems Micro fasteners High-strength structural fasteners Axle swage, latches, heat shields, pins, couplings, fittings, and other engineered products Attachments used on excavators and handheld tools The Industrial segment sells its products through a direct sales force and third-party distributors to various industries, including automotive, manufacturing, electronics, construction, and aerospace.
Barclays has an Overweight rating and a $95 target price on the shares.
Enterprise Products Partners (EPD - Free Report) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.
Over the past month, shares of this provider of midstream energy services have returned -8.4%, compared to the Zacks S&P 500 composite's +1.6% change. During this period, the Zacks Oil and Gas - Production Pipeline - MLB industry, which Enterprise Products falls in, has lost 6.6%. The key question now is: What could be the stock's future direction?
Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision.
Earnings Estimate RevisionsHere at Zacks, we prioritize appraising the change in the projection of a company's future earnings over anything else. That's because we believe the present value of its future stream of earnings is what determines the fair value for its stock.
We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors' interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
Enterprise Products is expected to post earnings of $0.73 per share for the current quarter, representing a year-over-year change of +10.6%. Over the last 30 days, the Zacks Consensus Estimate has changed +4.5%.
The consensus earnings estimate of $2.98 for the current fiscal year indicates a year-over-year change of +12%. This estimate has changed +1.8% over the last 30 days.
For the next fiscal year, the consensus earnings estimate of $3.29 indicates a change of +10.6% from what Enterprise Products is expected to report a year ago. Over the past month, the estimate has changed +1.6%.
With an impressive externally audited track record, our proprietary stock rating tool -- the Zacks Rank -- is a more conclusive indicator of a stock's near-term price performance, as it effectively harnesses the power of earnings estimate revisions. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #3 (Hold) for Enterprise Products.
The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:
12 Month EPS
Projected Revenue GrowthEven though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial.
In the case of Enterprise Products, the consensus sales estimate of $13.49 billion for the current quarter points to a year-over-year change of +18.7%. The $56.02 billion and $60.61 billion estimates for the current and next fiscal years indicate changes of +6.5% and +8.2%, respectively.
Last Reported Results and Surprise HistoryEnterprise Products reported revenues of $14.39 billion in the last reported quarter, representing a year-over-year change of -6.7%. EPS of $0.68 for the same period compares with $0.64 a year ago.
Compared to the Zacks Consensus Estimate of $13.19 billion, the reported revenues represent a surprise of +9.03%. The EPS surprise was -4.23%.
Over the last four quarters, Enterprise Products surpassed consensus EPS estimates two times. The company topped consensus revenue estimates two times over this period.
ValuationNo investment decision can be efficient without considering a stock's valuation. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance.
Comparing the current value of a company's valuation multiples, such as its price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), to its own historical values helps ascertain whether its stock is fairly valued, overvalued, or undervalued, whereas comparing the company relative to its peers on these parameters gives a good sense of how reasonable its stock price is.
As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.
Enterprise Products is graded B on this front, indicating that it is trading at a discount to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.
ConclusionThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Enterprise Products. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.
The S&P 500's dividend yield is near record lows at around 1%. That's making it a bit more challenging to find quality higher-yielding stocks to generate durable dividend income. However, there are still some high-quality income stocks available today.
The energy sector has several top-flight high-yielding dividend stocks. Here are three excellent options for those with $1,000 (or less) to invest right now.
Image source: Getty Images.
Brookfield Infrastructure Brookfield Infrastructure (BIPC +0.76%)(BIP +0.54%) is a leading global infrastructure investor. The company owns and operates a diversified portfolio of economically crucial infrastructure across the utilities, transport, midstream, and data sectors. Most of its assets generate revenue under long-term contracts or government-regulated frameworks, providing it with stable, inflation-linked cash flows (85% of its funds from operations or FFO).
The company pays out 60% to 70% of its stable cash flows in dividends. It currently yields 4.5%. At that rate, a $1,000 investment would generate about $45 of annual dividend income.
Brookfield retains the remainder of its cash flow to help fund its growth. The company's growth drivers include inflation-linked contractual rate increases, volume growth as the global economy expands, capital projects, and acquisitions. It currently has over $9.1 billion of capital projects underway, including new data centers, two semiconductor fabrication complexes, and utility expansions. Additionally, Brookfield has secured over $1.5 billion in new investments in the past year, including an investment in a leading U.S. refined petroleum products pipeline system.
Today's Change
(
0.76
%) $
0.30
Current Price
$
39.61
Brookfield Infrastructure's growth drivers should fuel more than 10% annual FFO per share growth going forward. That should support annual dividend growth of 5% to 9%. Brookfield has increased its dividend for 17 straight years (every year since its formation), growing it at a 9% compound annual rate.
Clearway Energy Clearway Energy (CWEN +1.77%) is a leader in owning clean power generation capacity, including renewable energy and natural gas-fired power plants. It sells the electricity these assets produce to utilities and large corporations under long-term, fixed-rate power purchase agreements. Those contracts generate stable cash flow. Clearway targets paying less than 70% of its cash flow in dividends. It currently yields more than 4.5%.
Today's Change
(
1.77
%) $
0.65
Current Price
$
37.42
The company plans to invest over $3 billion into new clean energy projects, with the potential to invest more if it secures digital infrastructure investment opportunities and additional acquisitions. This investment level should support 7% to 8%+ annual cash flow per share growth through 2030. Meanwhile, Clearway believes it can grow its cash flow per share at a 5% to 8%+ annual rate beyond 2031.
Clearway's growth strategy should support continued dividend increases. The company has increased its payout every quarter since 2020.
Enterprise Products Partners Enterprise Products Partners (EPD +0.22%) is one of the country's largest energy midstream companies. The master limited partnership (MLP), which sends a Schedule K-1 Federal Tax form each year, operates pipelines, processing plants, petrochemical facilities, and export terminals. Most of its assets generate predictable cash flows secured by long-term contracts and government-regulated rate structures.
Today's Change
(
0.22
%) $
0.08
Current Price
$
36.60
The MLP currently has a distribution yield of more than 6%. It covered that payout by a comfortable 1.8 times last quarter. That enabled it to retain $1.5 billion in cash to reinvest in the partnership.
Enterprise Products Partners currently has $5.3 billion of major capital projects under construction, including new gas processing plants, a pipeline expansion, and some additional export capacity. It expects these projects to enter commercial service by the end of next year. They'll give the MLP more fuel to increase its high-yielding distribution. Enterprise Products Partners has already raised its payout for 27 consecutive years.
Top-notch income stocks Brookfield Infrastructure, Clearway Energy, and Enterprise Products Partners generate very stable cash flow, enabling them to support their high-yielding dividends and growth strategies. Those growth investments should provide these energy companies with the fuel to continue increasing their payouts. That makes them ideal high-yielding stocks to invest $1,000 in right now for income.
Key Takeaways EPD's 50,000-mile pipeline network and storage assets support stable cash flow generation.Nearly 90% of long-term contracts allow fee increases in inflationary business environments.Enterprise Products may gain incremental cash flows from major capital projects and backlogs. Enterprise Products Partners LP’s (EPD - Free Report) pipeline network spans more than 50,000 miles, transporting oil, natural gas and other commodities. The partnership also has more than 300 million barrels of liquid storage capacity, thereby generating stable cash flows.
The business model of Enterprise Products is inflation-protected because almost 90% of its long-term contracts include a provision for increasing fees when the business environment becomes inflationary. This is how the midstream energy player is able to safeguard its cash flow generation in all business scenarios.
EPD is also expected to generate incremental cash flows from its billions of dollars’ worth of key capital projects, which are either in service or set to come online. With the partnership’s business model being mostly inflation-protected and likely to generate incremental cash flows from project backlogs, the stock could be attractive for income seekers.
KMI & ENB Also Have Stable Business ModelsKinder Morgan Inc. (KMI - Free Report) and Enbridge Inc. (ENB - Free Report) are two other midstream energy majors. By the very nature of their businesses, both KMI and ENB also have predictable cash flows. This is because KMI and ENB generate stable fee-based earnings from their respective midstream assets.
EPD’s Price Performance, Valuation & EstimatesUnits of Enterprise Products have jumped 17.2% over the past year compared with the 10.6% improvement of the composite stocks belonging to the industry.
Image Source: Zacks Investment Research
From a valuation standpoint, EPD trades at a trailing 12-month enterprise value to EBITDA (EV/EBITDA) of 11.21X. This is below the broader industry average of 11.62X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for EPD’s 2026 earnings has not seen any revisions over the past seven days.
Image Source: Zacks Investment Research
Enterprise Products currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Listen to the audio version of this article (generated by AI).
Within days of its showy IPO, SpaceX (SPCX) has locked in a $60-billion deal to acquire up-and-coming AI coding agent Cursor.
The price tag exceeds what Elon Musk paid for Twitter. In fact, excluding the $1.25 trillion merger between SpaceX and xAI, it’s Musk’s largest acquisition to date.
SpaceX just raised $75 billion in the largest IPO in history. It could have bought almost anything. It bought a coding agent.
That choice tells you everything about where Elon Musk thinks the next phase of AI is headed.
Why SpaceX Needed Cursor: The Software Problem at the Heart of the Musk Industrial Stack SpaceX’s entire business is centered on rockets, satellites, Starlink terminals, defense systems, autonomous manufacturing lines, humanoid robots, orbital compute infrastructure — and now, through xAI, a large language model.
Every single one of these businesses runs hyper-complex, mission-critical, continuously-iterated software.
If Cursor can make the engineers behind that software more productive, it could compress years of engineering work into months — across rockets, satellites, humanoid robots, and autonomous manufacturing lines simultaneously.
This impact goes deeper still. Cursor isn’t just a productivity tool; it’s a distribution platform. Enterprise developer tools are famously sticky. That means SpaceX just bought daily, persistent, deeply embedded access to the most valuable users in the enterprise software economy: software engineers.
Not to mention — every prompt, every code completion, every debugging session that runs through Cursor? That proprietary usage data is what makes AI models demonstrably better. SpaceX/xAI now owns one of the richest AI training and inference datasets on Earth, packaged inside a tool that users will pay a monthly subscription to provide.
That $60-billion price tag is starting to look much less outlandish.
(While Musk signals his moves publicly, others do it through SEC filings most investors never read. One of those filings just caught my attention.)
The Real Signal: AI Is Moving From the Training Room to Persistent Agentic Deployment For the past three years, the AI economy has been defined by one thing: training. Who has the most GPUs? Who can build the biggest model?
That’s what moved markets — and it was where the money went.
That era isn’t over, but it is maturing. The frontier labs have their models. The hyperscalers have their infrastructure. Now the race is about deployment; specifically, agentic deployment — AI that doesn’t just respond to prompts but takes actions, writes code, browses the web, executes tasks, and operates autonomously across multi-step workflows.
Cursor is the clearest proof yet that agentic AI coding is a daily workflow for millions of professional developers.
And when the world shifts toward continuously running AI agents, inference demand explodes. We’re talking 20x to 50x the compute from training-era workloads — because inference isn’t a one-and-done query. It’s a persistent, context-heavy, multi-turn process that runs all day, every day.
The SpaceX/Cursor deal is a $60 billion vote of confidence that the agentic shift is happening now, and the infrastructure to support it is worth building — at any price.
The Jevons Paradox Is About to Hit Software — and It’s Bullish for Every Physical Bottleneck There’s a principle in economics called Jevons Paradox: when a resource becomes more efficient to use, total consumption of that resource goes up.
For example, when James Watt’s improved steam engine made coal-powered machinery dramatically more efficient in the late 18th century, Britain didn’t use less coal — it used exponentially more. More efficient engines made steam power viable for textile mills, iron foundries, flour mills, breweries, railways, and steamships. Applications multiplied faster than efficiency gains could reduce consumption. By the time Jevons wrote his famous treatise in 1865, British coal output had roughly quadrupled in a generation.
The same dynamic is unfolding in software development right now.
AI coding agents like Cursor make software dramatically cheaper and faster to build. The first-order intuition is that this reduces infrastructure demand: fewer engineer-hours means less compute, right? Wrong.
When software becomes faster and cheaper to build, the world builds vastly more software. More software built by agents → more agent usage → more inference compute demand → more GPUs, more networking, more memory, more power, more cooling.
The Cursor acquisition doesn’t just validate agentic AI. It validates the entire AI infrastructure thesis for the next decade.
Where Does the $60 Billion Signal Point? The Physical Bottlenecks of Agentic AI Nobody got rich from cheaper steam engines. They got rich owning the coal mines, the railroads, and the infrastructure that made the boom possible. The AI version of that trade is right in front of us.
As agentic AI demand multiplies over the next few years, the components that are hardest to scale, fastest to sell out, and least substitutable will capture the most value. Here’s what’s on that list.
GPUs and Accelerators: The First Bottleneck Agentic Inference Pounds Inference workloads run on the same GPU infrastructure as training — and agentic inference is far more compute-intensive because it runs continuously rather than in discrete bursts.
Nvidia (NVDA) remains the dominant supplier, with Broadcom (AVGO) building custom AI chips for Google and Meta (META) that handle a growing share of hyperscaler inference. The GPU shortage is structural, and persistent agentic workloads are about to make it dramatically worse.
Networking: The Least Appreciated Bottleneck in the Agentic Stack Every token an AI agent generates has to move between memory and processors at extraordinary speeds — and when thousands of agents run simultaneously across distributed clusters, the data movement problem rivals the compute problem.
Arista Networks (ANET) is the backbone of AI cluster networking, handling the high-speed switching between GPU racks. Corning (GLW) and Coherent (COHR) supply the fiber and optical transceivers carrying that data between data centers — the last physical bottleneck before raw compute. Memory and Storage: Why Agentic AI Is Structurally Undersupplied Agentic AI is extraordinarily memory-hungry. Long context windows, persistent state, real-time retrieval — all of it demands high-bandwidth memory (HBM) that the industry is already structurally undersupplied on.
Micron (MU) is the leading U.S. supplier of HBM and has reportedly sold out production under long-term contracts. Western Digital (WDC) supplies the storage layer underneath. IREN (IREN) operates AI-native data center infrastructure built specifically around these workloads. Power and Cooling: The Bottleneck That Doesn’t Sleep Every GPU running inference burns power around the clock — and agentic workloads don’t sleep. A single large AI data center can consume as much electricity as a small city.
Vertiv (VRT) supplies the power and thermal management systems keeping those racks online. Eaton (ETN) provides the electrical infrastructure distributing power at scale. Quanta Services (PWR) builds and maintains the physical grid upgrades supporting the entire buildout — a decade-long capex cycle that is just getting started. The Bottom Line: Own the Bottlenecks the $60 Billion Signal Points To SpaceX’s latest deal isn’t really about Cursor. It’s about Elon Musk signaling that the next phase of AI is agentic, it runs on inference, and controlling the daily workflow of software engineers is a strategic asset worth $60 billion.
When the smartest, most ruthlessly strategic operator in the technology industry pays 60 billion dollars to make a bet, the right response is to ask what he knows that the market hasn’t priced in yet — and then position accordingly.
The AI economy is shifting from training to inference. From occasional queries to persistent agents. From a few hyperscalers spending capex to the entire software-building world running on AI infrastructure 24/7/365.
The bottlenecks in that world — GPUs, networking, memory, power, cooling — are the assets you want to own.
Those bottlenecks aren’t a secret to everyone.
Peter Thiel recently filed a 13F showing he’d quietly liquidated every share of Nvidia, Apple, Microsoft, and Tesla he owned. Not trimmed — exited entirely. At the same time, his private fund has been deploying capital into exactly the physical bottlenecks this piece describes: energy infrastructure, nuclear power, chip fabrication, and natural resources.
He can’t buy those companies publicly. Most of them aren’t available to retail investors at all.
But I have spent months identifying seven publicly traded stocks that mirror those same private bets — the physical layer of the AI buildout that the billionaires are already funding.
Thiel calls it the shift from “bits” to “atoms.” I call it the Billionaire’s Backdoor.
Here’s the full portfolio — and the thesis behind every position.
In the latest trading session, Arista Networks (ANET - Free Report) closed at $164.93, marking a -1.83% move from the previous day. The stock's change was less than the S&P 500's daily loss of 1.22%. At the same time, the Dow lost 0.98%, and the tech-heavy Nasdaq lost 1.35%.
Shares of the cloud networking company witnessed a gain of 18.67% over the previous month, beating the performance of the Computer and Technology sector with its gain of 1.19%, and the S&P 500's gain of 1.56%.
The investment community will be closely monitoring the performance of Arista Networks in its forthcoming earnings report. The company is forecasted to report an EPS of $0.89, showcasing a 21.92% upward movement from the corresponding quarter of the prior year. In the meantime, our current consensus estimate forecasts the revenue to be $2.82 billion, indicating a 27.95% growth compared to the corresponding quarter of the prior year.
For the entire fiscal year, the Zacks Consensus Estimates are projecting earnings of $3.63 per share and a revenue of $11.57 billion, representing changes of +21.81% and +28.46%, respectively, from the prior year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Arista Networks. Such recent modifications usually signify the changing landscape of near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 0.27% lower. Arista Networks currently has a Zacks Rank of #3 (Hold).
Looking at valuation, Arista Networks is presently trading at a Forward P/E ratio of 46.24. This indicates a premium in contrast to its industry's Forward P/E of 18.64.
It is also worth noting that ANET currently has a PEG ratio of 2.33. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. As of the close of trade yesterday, the Internet - Software industry held an average PEG ratio of 1.03.
The Internet - Software industry is part of the Computer and Technology sector. With its current Zacks Industry Rank of 86, this industry ranks in the top 36% of all industries, numbering over 250.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.
Characteristics and Risks of Standardized Options: https://bit.ly/2v9tH6D Keybanc raised its price target on Arista Networks (ANET) to $200 from $170 and maintains an overweight rating. @CharlesSchwab's Kevin Horner turns to the stock chart and explains how traders maintained and lifted long-term support, signaling strength in bullish trends.
Investors might want to bet on Moog (MOG.A - Free Report) , as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices.
The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.
Since a changing earnings picture is a powerful factor influencing near-term stock price movements, the Zacks rating system is very useful for individual investors. They may find it difficult to make decisions based on rating upgrades by Wall Street analysts, as these are mostly driven by subjective factors that are hard to see and measure in real time.
Therefore, the Zacks rating upgrade for Moog basically reflects positivity about its earnings outlook that could translate into buying pressure and an increase in its stock price.
Most Powerful Force Impacting Stock PricesThe change in a company's future earnings potential, as reflected in earnings estimate revisions, has proven to be strongly correlated with the near-term price movement of its stock. The influence of institutional investors has a partial contribution to this relationship, as these big professionals use earnings and earnings estimates to calculate the fair value of a company's shares. An increase or decrease in earnings estimates in their valuation models simply results in higher or lower fair value for a stock, and institutional investors typically buy or sell it. Their bulk investment action then leads to price movement for the stock.
For Moog, rising earnings estimates and the consequent rating upgrade fundamentally mean an improvement in the company's underlying business. And investors' appreciation of this improving business trend should push the stock higher.
Harnessing the Power of Earnings Estimate RevisionsEmpirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock movements, so it could be truly rewarding if such revisions are tracked for making an investment decision. Here is where the tried-and-tested Zacks Rank stock-rating system plays an important role, as it effectively harnesses the power of earnings estimate revisions.
The Zacks Rank stock-rating system, which uses four factors related to earnings estimates to classify stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record, with Zacks Rank #1 stocks generating an average annual return of +25% since 1988. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here >>>> .
Earnings Estimate Revisions for MoogThis aerospace contractor is expected to earn $10.61 per share for the fiscal year ending September 2026, which represents no year-over-year change.
Analysts have been steadily raising their estimates for Moog. Over the past three months, the Zacks Consensus Estimate for the company has increased 4.5%.
Bottom LineUnlike the overly optimistic Wall Street analysts whose rating systems tend to be weighted toward favorable recommendations, the Zacks rating system maintains an equal proportion of "buy" and "sell" ratings for its entire universe of more than 4,000 stocks at any point in time. Irrespective of market conditions, only the top 5% of the Zacks-covered stocks get a "Strong Buy" rating and the next 15% get a "Buy" rating. So, the placement of a stock in the top 20% of the Zacks-covered stocks indicates its superior earnings estimate revision feature, making it a solid candidate for producing market-beating returns in the near term.
You can learn more about the Zacks Rank here >>>
The upgrade of Moog to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the near term.
For those looking to find strong Transportation stocks, it is prudent to search for companies in the group that are outperforming their peers. Has ArcBest (ARCB - Free Report) been one of those stocks this year? Let's take a closer look at the stock's year-to-date performance to find out.
ArcBest is one of 99 individual stocks in the Transportation sector. Collectively, these companies sit at #3 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.
The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. ArcBest is currently sporting a Zacks Rank of #1 (Strong Buy).
Within the past quarter, the Zacks Consensus Estimate for ARCB's full-year earnings has moved 23.2% higher. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.
According to our latest data, ARCB has moved about 94.8% on a year-to-date basis. Meanwhile, stocks in the Transportation group have gained about 12.6% on average. This means that ArcBest is performing better than its sector in terms of year-to-date returns.
Another stock in the Transportation sector, TFI International Inc. (TFII - Free Report) , has outperformed the sector so far this year. The stock's year-to-date return is 40.7%.
In TFI International Inc.'s case, the consensus EPS estimate for the current year increased 12.1% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, ArcBest belongs to the Transportation - Truck industry, which includes 12 individual stocks and currently sits at #45 in the Zacks Industry Rank. On average, stocks in this group have gained 41.6% this year, meaning that ARCB is performing better in terms of year-to-date returns.
In contrast, TFI International Inc. falls under the Transportation - Services industry. Currently, this industry has 19 stocks and is ranked #101. Since the beginning of the year, the industry has moved +10.2%.
Investors interested in the Transportation sector may want to keep a close eye on ArcBest and TFI International Inc. as they attempt to continue their solid performance.
New data solution enhances usability, transparency and decision-making amid UK and EU transparency reforms
LONDON--(BUSINESS WIRE)--MarketAxess Holdings Inc. (Nasdaq: MKTX) today announced the launch of TraX® Tape, a data solution that delivers a clean, consolidated view of bond market activity, enriched with additional context and real-time insights.
Built on MarketAxess TraX data, TraX Tape aggregates data from a global network of dealers and clients and applies proprietary data cleansing processes refined over 10 years.
Share The launch comes as UK and EU transparency reforms increase the availability of bond trading data while adding complexity to how that data is reported and interpreted. TraX Tape addresses these challenges by providing a single, standardised feed that consolidates and enhances market data, enabling clients to interpret trading activity more efficiently and with greater confidence.
“Market participants have more data than ever but turning that data into actionable insight remains a challenge,” said Dean Berry, Group COO and CEO of EMEA & APAC at MarketAxess. “TraX Tape is designed to deliver a clearer and more complete view of market activity, helping clients make more informed trading decisions.”
Built on MarketAxess TraX data, TraX Tape aggregates data from a global network of dealers and clients and applies proprietary data cleansing processes refined over 10 years. The solution then enriches the regulatory transparency data with additional real-time insights and analytics, including trade direction and pricing context from MarketAxess’ AI-powered pricing engine CP+™.
Key features include:
Directional indicators on each trade, providing clearer insight into market sentiment A consolidated view of global bond trading activity through a single connection Clean, de-duplicated data to improve usability and reduce operational burden Expanded coverage and earlier visibility into trading activity Integrated analytics, including yield and spread calculations, to support trading and execution analysis “The consolidated tape will bring increased transparency and standardisation to global bond markets,” Berry added. “TraX Tape builds upon that foundation and brings clarity with contextual intelligence that can only come from seeing how bonds actually trade on one of the world’s largest electronic credit platforms. The data tells you what happened, and TraX Tape tells you what it means.”
About MarketAxess
MarketAxess (Nasdaq: MKTX) operates a leading electronic trading platform that delivers greater trading efficiency, a diversified pool of liquidity and significant cost savings to institutional investors and broker-dealers across the global fixed-income and other markets. Approximately 2,100 firms leverage MarketAxess’ patented technology to efficiently trade fixed-income securities. Our automated and algorithmic trading solutions, combined with our integrated and actionable data offerings, help our clients make faster, better-informed decisions on when and how to trade on our platform. MarketAxess’ award-winning Open Trading® marketplace is widely regarded as the preferred all-to-all trading solution in the global credit markets. Founded in 2000, MarketAxess connects a robust network of market participants through an advanced full trading lifecycle solution that includes automated trading solutions, intelligent data and index products and a range of post-trade services. Learn more at www.marketaxess.com and on X @MarketAxess.
This press release may contain forward-looking statements, including statements about the outlook and prospects for MarketAxess Holdings Inc. (the “Company” or “MarketAxess”), market conditions and industry growth, as well as statements about the Company’s future financial and operating performance. These and other statements that relate to future results and events are based on MarketAxess’ current expectations. The Company’s actual results in future periods may differ materially from those currently expected or desired because of a number of risks and uncertainties, including: global economic, political and market factors; the level of trading volume transacted on the MarketAxess platform; the rapidly evolving nature of the electronic financial services industry; the level and intensity of competition in the fixed-income electronic trading industry and the pricing pressures that may result; the variability of our growth rate; our ability to introduce new fee plans and our clients’ response; our ability to attract clients or adapt our technology and marketing strategy to new markets; risks related to our growing international operations; our dependence on our broker-dealer clients; the loss of any of our significant institutional investor clients; our exposure to risks resulting from non-performance by counterparties to transactions executed between our clients in which we act as an intermediary in matched principal trades; risks related to self-clearing; our dependence on third-party suppliers for key products and services; our ability to enter into strategic alliances and to acquire other businesses and successfully integrate them with our business; our dependence on our management team and our ability to attract and retain talent; risks related to sanctions levied against states or individuals that could expose us to operational or regulatory risks; the effects of climate change or other sustainability risks that could affect our operations or reputation; the effect of rapid market or technological changes on us and the users of our technology; issues related to the development and use of artificial intelligence; our ability to successfully maintain the integrity of our trading platform and our response to system failures, capacity constraints and business interruptions; the occurrence of design defects, errors, failures or delays with our platforms, products or services; our vulnerability to malicious cyber-attacks and attempted cybersecurity breaches; our actual or perceived failure to comply with privacy and data protection laws; our ability to protect our intellectual property rights or technology and defend against intellectual property infringement or other claims; our use of open-source software; limitations on our flexibility because we operate in a highly regulated industry; the increasing government regulation of us and our clients; our exposure to costs and penalties related to our extensive regulation; our risks of litigation and securities laws liability; our tax filing positions; our future capital needs and our ability to obtain capital when needed; limitations on our operating flexibility contained in our credit agreement; our exposure to financial institutions by holding cash in excess of federally insured limits; and other factors. The Company undertakes no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise. More information about these and other factors affecting MarketAxess’ business and prospects is contained in MarketAxess’ periodic filings with the Securities and Exchange Commission and can be accessed at www.marketaxess.com.
Key Takeaways MarketAxess introduced TraX Tape to provide a consolidated view of global bond trading activity.MKTX uses data cleansing, de-duplication and analytics to improve trade interpretation.MKTX expands recurring data and analytics offerings as bond markets become more data-driven. MarketAxess Holdings Inc. (MKTX - Free Report) recently launched TraX Tape, a new data solution designed to provide market participants with a clearer and more comprehensive view of global bond trading activity. The launch comes as regulatory transparency reforms in the United Kingdom and European Union increase the amount of bond trading data available to market participants, creating new challenges around data interpretation and usability.
TraX Tape delivers a consolidated view of bond trading activity through a single standardized feed. The solution is built on MarketAxess’ TraX data network, which gathers information from a broad network of dealers and clients. The data is then processed through cleansing and de-duplication techniques to provide a clearer and more streamlined view of market activity.
Beyond aggregation, the platform enriches trading data with additional insights designed to improve market interpretation. Features include trade-direction indicators, expanded visibility into trading activity and integrated analytics such as yield and spread calculations. The solution also incorporates pricing context generated by MKTX’s AI-powered CP+ pricing engine, adding another layer of market intelligence.
MarketAxess has been steadily broadening its business beyond trade execution by investing in data, analytics and pricing solutions. This strategy is important because data-related offerings typically generate recurring revenues and are less dependent on fluctuations in trading volumes. By expanding its suite of intelligence tools, the company is strengthening an area that can complement its core electronic trading platform while enhancing the overall value proposition for clients.
The bond market is becoming increasingly data-driven as electronic trading adoption continues to rise and regulatory reporting requirements expand. In this environment, the competitive advantage is shifting from simply providing access to data toward delivering meaningful insights from that information. TraX Tape positions MarketAxess to capitalize on this trend by offering tools that help users interpret trading activity more efficiently, potentially creating additional opportunities for growth within its data and analytics business.
MKTX’s Price PerformanceOver the past year, MKTX shares have declined 45.3% against the industry’s rise of 33.1%.
Image Source: Zacks Investment Research
MKTX’s Zacks Rank & Key PicksMKTX currently carries a Zacks Rank #4 (Sell).
Some better-ranked stocks in the broader finance space are Alerus Financial Corporation (ALRS - Free Report) , Pelagos Insurance Capital Ltd. (PLGO - Free Report) and Cboe Global Markets, Inc. (CBOE - Free Report) , each sporting a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Alerus Financial’s current-year earnings of $2.95 per share has witnessed two upward revisions in the past 60 days against none in the opposite direction. ALRS’ earnings beat estimates in each of the trailing four quarters, with the average surprise being 35.8%. The consensus estimate for current-year revenues is pegged at $306.2 million, suggesting a 3.8% year-over-year jump.
The consensus estimate for Pelagos Insurance Capital’s current-year earnings is pegged at $3.78 per share, which signals 96.9% year-over-year growth. Its earnings beat estimates in three of the trailing four quarters and missed once, with the average surprise being 53.6%. The consensus mark for PLGO’s current-year revenues of $2.8 billion implies 11.4% year-over-year growth.
The consensus estimate for Cboe Global Markets’ current-year earnings is pegged at $13.34 per share, which has witnessed two upward revisions in the past 30 days against none in the opposite direction. Its earnings beat estimates in each of the trailing four quarters, with the average surprise being 5.4%. The consensus estimate for CBOE’s current-year revenues is pegged at $2.8 billion, which implies a 13.1% year-over-year rise.
Data, including seven oral presentations, highlight the clinical utility of Prospera™ across multiple organs
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced its robust scientific presence at the upcoming American Transplant Congress (ATC), taking place June 20-24, 2026. The company and its collaborators will share 21 presentations, including seven oral presentations, highlighting the utility of the Prospera test to inform risk assessment and long-term graft monitoring across kidney, heart, lung, and multi-organ transplant.
Some of the most anticipated Prospera study data to be shared include:
Even when biopsy results are negative for rejection, elevated Prospera dd-cfDNA levels were strongly predictive of future adverse outcomes, including eGFR decline, DSA positivity, and graft loss. New data from the PEDAL study in 346 kidney transplant patients with non-rejection biopsy results showed that patients with positive Prospera results, which occurred in 18.2% of these cases, had significantly higher rates of adverse outcomes, including >6X the rate of graft loss. The data suggest that positive dd-cfDNA results indicate an increased risk for adverse outcomes, even when biopsy does not show rejection.Patients with persistently low Prospera dd-cfDNA levels had reliable and significantly lower adverse outcome rates, which may enable confident decisions to lower immunosuppression. In a new analysis of 989 kidney transplant recipients from the ProActive study, when a patient’s Prospera dd-cfDNA donor-fraction remained <0.5%, patients had significantly lower rates of adverse outcomes, including ~12X reduced odds of future rejection and ~5.5X reduced odds of future graft loss. These results demonstrate that low Prospera dd-cfDNA was prognostic of durable graft stability and reiterate the importance of ongoing and regular monitoring."Natera is leading the next phase of studies and evidence generation for dd-cfDNA,” said Sangeeta Bhorade, M.D., chief medical officer, organ health, Natera. “It is well established that Prospera identifies rejection, and our new data, like that from PEDAL and ProActive, are evaluating its impact on real clinical decision making for transplant patients. These data reinforce the importance of using the Prospera test regularly as a non-invasive way to monitor patients and help guide care decisions that may support longer graft life and better outcomes.”
Full list of Natera presentations at ATC:
June 20, 5:45 PM ET | Abstract #A003
Presenter: Catherine Spellicy, Ph.D.
The Edge of Detection: Defining Critical Thresholds for the Prospera Donor-Derived Cell-Free DNA Transplant Rejection Screen
June 20, 5:45 PM ET | Abstract #A363 (ProActive)
Presenter: Jonathan Bromberg, M.D., Ph.D.
Consistently Low Donor-Derived Cell-Free DNA Identifies Allograft Stability in Kidney Transplant Recipients
June 20, 5:45 PM ET | Abstract #A380
Presenter: Mita Banik, Ph.D.
A Novel Hierarchical Machine Learning Framework for Predicting Kidney Transplant Rejection Subtype
June 21, 8:30 AM ET | Abstract #254
Presenter: Ginger DeLario, Ph.D., M.T. (ASCP), CPTC
Are Transplant APPs Ready for Certification? National Findings from the American Board for Transplant Certification (ABTC)
June 21, 2:45 PM ET | Abstract #B258
Presenter: Quinn Stein, M.S., CGC
Busting the Age Myth: Clinically Significant Genetic Findings in Living Donor Candidates Are Not Limited to the Young
June 21, 2:45 PM ET | Abstract #B261
Presenter: Keysha M. López Vega, M.D.
Genetic Testing in Kidney Transplant Candidates and Recipients: Three Cases of Adenine Phosphoribosyltransferase (APRT) Deficiency Identified in Puerto Rico
June 21, 2:45 PM ET | Abstract #B266
Presenter: Maggie Westemeyer, M.S., CGC
Positive Genetic Test Results in Living Kidney Donor Candidates: Common and Broadly Distributed Across Genes
June 21, 5:00 PM ET | Abstract #490 (Oral Presentation)
Presenter: Quinn Stein, M.S., CGC
Carrier Findings Are Common and Clinically Relevant in Living Kidney Donor Candidates
June 22, 8:15 AM ET | Abstract #554 (Trifecta Heart, Oral Presentation)
Presenter: Katelynn Madill-Thomsen, Ph.D.
In heart transplants, DSA-negative and DSA-positive antibody-mediated rejection have similar molecular features, timing, dd-cfDNA and leukocyte composition
June 22, 2:45 PM ET | Abstract #C090
Presenter: Gregory Lewis, M.D.
Biopsy to Biomarker: Evolution of Post-Heart Transplant Surveillance Practices from the ProTECT Study
June 22, 2:45 PM ET | Abstract #C093 (Trifecta Heart)
Presenter: Martina Mackova, Ph.D.
Comparing Histological Acute Cellular Rejection Grade 1R with Molecular Microscope® Diagnostic System Classifiers and Donor-Derived Cell-Free DNA (dd-cfDNA) Levels
June 22, 2:45 PM ET | Abstract #C100 (Trifecta Heart)
Presenter: Patrick Gauthier, Ph.D.
Incremental Increase in Donor-Derived Cell-Free DNA (dd-cfDNA) and Risk of Molecular Rejection in Heart Transplant (HT) Recipients
June 22, 2:45 PM ET | Abstract #C157
Presenter: Meg Hager, M.S., MPH, CGC
Conversations That Lead to Action: Genetic Counselors and Living Kidney Donors
June 22, 2:45 PM ET | Abstract #C358
Presenter: Shelley Hall, M.D.
Donor-Derived Cell-Free DNA (dd-cfDNA) and Clinical Outcomes in Heart Transplant (HT) Patients (Pts) with Antibody Mediated Rejection (AMR): ProTECT Study
June 23, 2:30 PM ET | Abstract #D083 (ProActive)
Presenter: Matthew Cooper, M.D.
Association Between dd-cfDNA and Future Development of DSA or Rejection in Kidney Transplant Recipients with TCMR
June 23, 2:30 PM ET | Abstract #D120 (ProActive)
Presenter: Sanjeev Akkina, M.D.
Dd-cfDNA in Kidney Transplant Recipients (KTRs) with Cancer
June 23, 2:30 PM ET | Abstract #D266
Presenter: Justin Rosenheck, D.O.
Torque Teno Virus (TTV) Viral Load (VL) Correlates with Tacrolimus (TAC) Levels but Not Lymphocyte Subsets or Immunoglobulins After Lung Transplantation (LT)
June 23, 2:30 PM ET | Abstract # D285
Presenter: Abraham Matar, M.D.
Donor-Derived Cell-Free DNA for Detection of Rejection After Pancreas Transplantation
June 24, 9:30 AM ET | Abstract #1314 (Trifecta Heart, Oral Presentation)
Presenter: Martina Mackova, Ph.D.
In Heart Transplants Current Standard-of-Care Management of TCMR and ABMR is Often Associated with Persistence of Molecular Rejection and Elevated dd-cfDNA
June 24, 9:30 AM ET | Abstract #1316 (Trifecta Kidney, Oral Presentation)
Presenter: Philip Halloran, M.D.
Current Standard-of-Care Management of TCMR and ABMR in Kidney Transplant Patients is Associated with Persistence of Molecular Rejection and Elevated dd-cfDNA
June 24, 9:30 AM ET | Abstract #1331 (Oral Presentation)
Presenter: Gaurav Gupta, M.D.
Donor-Derived Cell-Free DNA in Pancreas-Kidney, Heart-Kidney, and Liver-Kidney Multiorgan Transplant Recipients (MOTR)
June 24, 9:30 AM ET | Abstract #1333 (PEDAL, Oral Presentation)
Presenter: Yasir Qazi, M.D., Ph.D., FACS
Post-Rejection Donor-Derived Cell-Free DNA and Serum Creatinine Trends in Kidney Transplant Recipients
June 24, 9:30 AM ET | Abstract #1335 (PEDAL, Oral Presentation)
Presenter: Suphamai Bunnapradist, M.D.
Donor-Derived Cell-Free DNA as a Prognostic Biomarker in Biopsy-Negative Kidney-Transplant Recipients
About Natera
Natera™ is a global leader in cell-free DNA and precision medicine, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard-of-care to protect health and inform earlier, more targeted interventions that help lead to longer, healthier lives. Natera’s tests are supported by more than 400 peer-reviewed publications that demonstrate excellent performance. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas, and San Carlos, California, and through Foresight Diagnostics, its subsidiary, operates an ISO 27001-certified and CAP-accredited laboratory certified under CLIA in Boulder, Colorado. For more information, visit www.natera.com.
Forward-Looking Statements
All statements other than statements of historical facts contained in this press release are forward-looking statements and are not a representation that Natera’s plans, estimates, or expectations will be achieved. These forward-looking statements represent Natera’s expectations as of the date of this press release, and Natera disclaims any obligation to update the forward-looking statements. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially, including with respect to whether the results of clinical or other studies will support the use of our product offerings, the impact of results of such studies, our expectations of the reliability, accuracy, and performance of our tests, or of the benefits of our tests and product offerings to patients, providers, and payers. Additional risks and uncertainties are discussed in greater detail in "Risk Factors" in Natera’s recent filings on Forms 10-K and 10-Q, and in other filings Natera makes with the SEC from time to time. These documents are available at www.natera.com/investors and www.sec.gov.
MongoDB has rebounded ~50% from YTD lows, driven by surging AI-driven demand for its unstructured database products. MDB raised FY27 guidance to $2.92–$2.96 billion (19–20% growth), with the new low end exceeding prior guidance's high end. At 8.3x EV/FY27 revenue, MDB trades at a premium to application software peers but at a discount to infrastructure software names with similar growth.
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about CRH (CRH - Free Report) .
CRH currently has an average brokerage recommendation (ABR) of 1.14, on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell, etc.) made by 21 brokerage firms. An ABR of 1.14 approximates between Strong Buy and Buy.
Of the 21 recommendations that derive the current ABR, 19 are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 90.5% and 4.8% of all recommendations.
Brokerage Recommendation Trends for CRH
Check price target & stock forecast for CRH here>>>
While the ABR calls for buying CRH, it may not be wise to make an investment decision solely based on this information. Several studies have shown limited to no success of brokerage recommendations in guiding investors to pick stocks with the best price increase potential.
Do you wonder why? As a result of the vested interest of brokerage firms in a stock they cover, their analysts tend to rate it with a strong positive bias. According to our research, brokerage firms assign five "Strong Buy" recommendations for every "Strong Sell" recommendation.
In other words, their interests aren't always aligned with retail investors, rarely indicating where the price of a stock could actually be heading. Therefore, the best use of this information could be validating your own research or an indicator that has proven to be highly successful in predicting a stock's price movement.
With an impressive externally audited track record, our proprietary stock rating tool, the Zacks Rank, which classifies stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), is a reliable indicator of a stock's near-term price performance. So, validating the Zacks Rank with ABR could go a long way in making a profitable investment decision.
ABR Should Not Be Confused With Zacks RankAlthough both Zacks Rank and ABR are displayed in a range of 1--5, they are different measures altogether.
The ABR is calculated solely based on brokerage recommendations and is typically displayed with decimals (example: 1.28). In contrast, the Zacks Rank is a quantitative model allowing investors to harness the power of earnings estimate revisions. It is displayed in whole numbers -- 1 to 5.
Analysts employed by brokerage firms have been and continue to be overly optimistic with their recommendations. Since the ratings issued by these analysts are more favorable than their research would support because of the vested interest of their employers, they mislead investors far more often than they guide.
On the other hand, earnings estimate revisions are at the core of the Zacks Rank. And empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
In addition, the different Zacks Rank grades are applied proportionately to all stocks for which brokerage analysts provide current-year earnings estimates. In other words, this tool always maintains a balance among its five ranks.
Another key difference between the ABR and Zacks Rank is freshness. The ABR is not necessarily up-to-date when you look at it. But, since brokerage analysts keep revising their earnings estimates to account for a company's changing business trends, and their actions get reflected in the Zacks Rank quickly enough, it is always timely in indicating future price movements.
Is CRH Worth Investing In?In terms of earnings estimate revisions for CRH, the Zacks Consensus Estimate for the current year has remained unchanged over the past month at $5.92.
Analysts' steady views regarding the company's earnings prospects, as indicated by an unchanged consensus estimate, could be a legitimate reason for the stock to perform in line with the broader market in the near term.
The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #3 (Hold) for CRH. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
It may therefore be prudent to be a little cautious with the Buy-equivalent ABR for CRH.
CRH (CRH - Free Report) closed the most recent trading day at $111.24, moving +1.67% from the previous trading session. The stock's change was more than the S&P 500's daily gain of 1.09%. At the same time, the Dow added 0.14%, and the tech-heavy Nasdaq gained 1.91%.
Shares of the building material company have appreciated by 7.85% over the course of the past month, outperforming the Construction sector's gain of 3.92%, and the S&P 500's gain of 0.29%.
The upcoming earnings release of CRH will be of great interest to investors. It is anticipated that the company will report an EPS of $1.96, marking a 1.03% rise compared to the same quarter of the previous year. Alongside, our most recent consensus estimate is anticipating revenue of $10.67 billion, indicating a 4.57% upward movement from the same quarter last year.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $5.92 per share and revenue of $39.84 billion. These totals would mark changes of +6.28% and +6.39%, respectively, from last year.
It is also important to note the recent changes to analyst estimates for CRH. Such recent modifications usually signify the changing landscape of near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. CRH is currently a Zacks Rank #3 (Hold).
Valuation is also important, so investors should note that CRH has a Forward P/E ratio of 18.49 right now. This signifies no noticeable deviation in comparison to the average Forward P/E of 18.49 for its industry.
It's also important to note that CRH currently trades at a PEG ratio of 1.9. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. The average PEG ratio for the Building Products - Miscellaneous industry stood at 1.54 at the close of the market yesterday.
The Building Products - Miscellaneous industry is part of the Construction sector. This group has a Zacks Industry Rank of 191, putting it in the bottom 22% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.
Eagle Materials (EXP) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Barrett recognized among 50 executives in American Banker’s first-ever ranking, reflecting Valley’s continued investment in digital transformation, AI readiness, and relationship-driven innovation
MORRISTOWN, N.J.--(BUSINESS WIRE)--Valley National Bank, (“Valley” or the “Bank”), a subsidiary of Valley National Bancorp (NASDAQ: VLY), today announced that Russell Barrett, Senior Executive Vice President and Chief Operating Officer, has been named to American Banker’s 2026 Most Innovative People in Finance list.
The ranking recognizes 50 executives across financial services whose leadership and execution are redefining what is possible across banking, payments, technology, customer experience, AI, and digital financial services. Barrett was selected for his role in architecting Valley’s enterprise technology foundation and advancing an innovation strategy designed to support scalable, long-term growth.
Since joining Valley in 2021, Barrett has led several of the Bank’s most consequential technology transformations, including the complete overhaul and modern conversion of the Bank's core banking architecture. Beyond expanding treasury and deposit capabilities for customers and improving operational efficiency, that effort created a more scalable foundation for future innovation.
Barrett has also overseen Valley’s cloud-first strategy, which includes the migration of more than 80% of the Bank’s data center capacity to the cloud and the development of a centralized enterprise data hub. Under his leadership, Valley has launched more than 50 digital transformation initiatives over the past year and has advanced AI-related applications across anti-money laundering, operational quality, sales effectiveness, and employee training.
Valley’s prioritization of AI technology reflects a broader strategic view articulated by CEO Ira Robbins in his May 2026 American Banker op-ed, which emphasized that AI should be utilized as a connectivity solution rather than a threat to modern banking. This perspective aligns with Valley’s continued investment in cloud infrastructure, data capabilities, and AI readiness.
“Russ has been central to building the technology foundation that has made Valley a stronger, faster, and more efficient organization,” said Ira Robbins, CEO of Valley Bank. “His leadership reflects how we view innovation, not as a buzzword, but as a disciplined, purposeful approach focused on creating lasting value for customers, associates, partners, and shareholders. This recognition is well-deserved and reflects the ambition and quality of work across our entire organization.”
Valley’s innovation strategy also extends to client-facing solutions. The bank has partnered with startups and leveraged internal engineering capabilities to develop business capabilities across numerous verticals like commercial lending, collateral management, and client information reporting. Valley has also built an embedded finance customer integration layer and in-market products that resolve client friction points, streamline operations, and reduce costs.
“Our goal is not to pursue innovation for its own sake,” Barrett said. “At Valley, we are focused on building the infrastructure, culture, and partnerships that allow us to use technology responsibly and effectively. Our investments in cloud, data, and AI readiness are helping us move faster, make better decisions, and deliver greater value to the customers and communities we serve, and we believe this is just the beginning.”
The Bank continues to expand its broader innovation ecosystem through Valley Foundry, its dedicated fintech exploration and emerging technology team, as well as Valley Ventures, Valley’s corporate venture capital arm focused on early-and growth-stage fintech and proptech companies. These initiatives help position Valley at the forefront of emerging technologies while accelerating the delivery of innovative solutions to customers.
That commitment to innovation was further reinforced by the recent appointment of Rodrigo Suarez as Head of Partner Banking, a strategic hire focused on expanding Valley’s fintech partnerships and payment platforms and a clear signal of the Bank's intent to move deeper into this space.
Together, these efforts represent Valley’s institution-wide commitment to strengthening its technology foundation, expanding strategic partnerships, and delivering forward-thinking solutions that meet evolving customer needs.
The American Banker profile on Barrett can be viewed here.
About Valley
As the principal subsidiary of Valley National Bancorp (NASDAQ: VLY), Valley National Bank is a regional financial institution with approximately $64 billion in assets. Founded in 1927, Valley has more than 220 branch locations and commercial offices nationwide and serves clients across New Jersey, New York, Florida, Alabama, California, Illinois, Pennsylvania, and Arizona. Valley delivers a full range of consumer, commercial, and wealth management solutions designed to support everything from homeownership and business growth to long-term financial planning. Big enough to support complex financial needs and small enough to stay deeply connected, Valley is grounded in a relationship-led approach focused on understanding people first. That same relationship-led approach guides Valley’s commitment to community investment and responsible corporate citizenship. To learn more, visit www.valley.com or call our Customer Care Center at 800-522-4100.
Flywire Corp (FLYW +2.79%) and Visa Inc (V 0.80%) both play vital roles in moving money, but they represent very different paths for your portfolio. This comparison examines their financials and risks to help you decide which fits your goals.
Flywire focuses on solving complex, high-value payment problems in specific industries like education and healthcare. Visa operates the massive underlying infrastructure that powers billions of daily transactions globally. We compare their financials and risks to help you decide which stock is the better buy.
The case for FlywireFlywire operates as a global payments enablement and software company, often categorized among high-growth tech stocks. It processes both cross-border and domestic payments for specialized clients in the education, healthcare, and travel industries. By focusing on these complex verticals, the company provides tailored software that automates high-value transactions for more than 5,100 clients across 240 countries.
In FY 2025, revenue reached $603 million, representing approximately 27% year-over-year growth. The company reported a net income of $13.5 million for the year, marking a notable improvement over prior years. This results in a net margin of roughly 2.2%, representing the percentage of total revenue remaining after the company pays all operating costs and taxes.
As of its December 2025 balance sheet, the company had no debt. The current debt level is just $1.45 million, compared to more than $325 million in cash on hand for the business, indicating the company has more than enough short-term assets to cover its immediate liabilities.
The case for VisaVisa operates as a global payments technology company that serves billions of consumers, businesses, and government entities. It enables digital payments to replace cash and checks in more than 200 countries and territories worldwide. This massive scale creates a powerful network effect where a growing number of cardholders makes the network more valuable to merchants.
In FY 2025, revenue reached $40 billion, representing approximately 11.4% growth over the previous year. The company reported a net income of nearly $20.1 billion for the same period. This results in a net margin of roughly 50.1%, indicating the percentage of each dollar of revenue retained as profit.
As of its September 2025 balance sheet, the debt-to-equity ratio is approximately 0.7x, which compares total debt to shareholder equity, a metric used to evaluate if a business can pay its short-term debts with its current assets. The current ratio is about that as well.
Risk profile comparisonFlywire faces risks from global government policies that restrict international student movement, such as visa caps in Canada, the U.S., and Australia. Geopolitical friction between major economies such as China and the U.S. also threatens to slow cross-border transaction volumes. Furthermore, intense competition from legacy payment providers puts constant pressure on the company to maintain its pricing and market share.
Visa operates under heavy regulatory scrutiny, specifically regarding the interchange fees it charges for processing transactions. The company faces stiff competition from other global networks like Mastercard (MA 0.48%) and American Express (AXP 0.51%), as well as new real-time payment systems. Additionally, any significant cybersecurity breach could lead to data loss and substantial regulatory fines.
Valuation comparisonVisa and Flywire are equally good buys based on their identical Forward P/E ratio, comparing price to future earnings estimates. Flywire carries a lower P/S ratio, measuring price against revenue.
MetricFlywireVisaSector BenchmarkForward P/E22.2x22.2x32.2xP/S ratio3.0x16.8xSector benchmark uses the SPDR XLK sector ETF.
Valuation metrics sourced from Financial Modeling Prep (FMP) and may differ from other data providers.
Encrypted payment system providers like Visa have been under attack from fintechs and neobanks for years, as a shift toward mobile banking and innovation in financial products and transaction speed has allowed new entrants like Flywire to gain a foothold.
While both companies are profitable —Visa more so —and have equal price-to-forward earnings ratios that are cheaper than the financial services sector overall, each has a forward P/E of 22.2 in recent trading; the younger and more nimble Flywire gets the nod.
The knee-jerk reaction to the U.S. tamping down on foreign students is that it’s bad for Flywire, which has established a strong niche in serving students. But the company’s experience with similar admissions tightening in Canada and Australia shows that such restrictions don’t reduce Flywire’s business; they simply shift where students go to school. Given that Flywire has a global network that is especially strong in countries like India, which send many students abroad, this doesn’t really affect its business.
The global nature of Flywire’s network — it accepts payments from 240 countries — has not only given it real strength in the student realm but has also enabled it to grow businesses in travel and health care, which see lots of cross-border payments. Revenue is expected to rise about 24% to $747 million this year, with net income improving. Growth-wise, Visa’s scale works against it: its sales are expected to rise about 14%, still impressive, but not at a forward price-to-sales ratio so much larger than its smaller competitor.
Equipped with new features including automatic zoom adjustment by AI and creating a comfortable space by lighting and sound
TOKYO, June 17, 2026 - (JCN Newswire) - Sharp Corporation introduces the AQUOS R11 high-end smartphone. In addition to a function that uses AI to automatically adjust the zoom level according to the subject, it newly features capabilities that create a comfortable space by lighting and sound. These enhancements not only improve usability during photography but also expand the ways users can enjoy their smartphones in everyday life. Sales will begin sequentially in Japan and Taiwan on and after July 9 of this year (*1).
The camera has been supervised by Leica Camera AG (Headquarters: Wetzlar, Germany). Equipped with a high-resolution triple camera system-50.3 MP standard, 50.3 MP ultra-wide, and 38.5 MP telephoto-it supports a wide range of shooting scenarios, from everyday snapshots to expansive landscapes and distant subjects.
AI-powered camera functions have also been further enhanced. The newly introduced Smart Fit Zoom allows users to simply tap a dedicated icon, after which AI automatically adjusts the zoom level according to the subject, enabling well-balanced compositions centered on the intended subject. In addition, the Privacy Safe feature (*2) automatically detects and masks (*3) text such as signs and billboards at the time of capture, helping protect privacy when sharing images on social media.
By combining ease of operation with natural, subject-optimized image results, the camera delivers a photography experience that embodies the concept: Simple, yet stunning.
The new Akarium feature uses a light positioned at the center of the rear camera ring to gently notify users of incoming calls, messages, and other alerts. The lighting incorporates eight colors inspired by hues found in nature. In addition, healing sounds recorded from nature, synchronized with lighting effects modeled after elements such as a campfire and a flowing stream, create a relaxing and comfortable atmosphere for moments like before bedtime or during breaks (*2).
The display features a high-brightness Pro IGZO OLED with a peak brightness of 3,600 nits. With its Smart Outdoor View feature, which brightens low-tone areas according to ambient lighting conditions, dark areas of images are clearly visible even under strong sunlight or in dim outdoor environments.
The device is powered by the Snapdragon(R) 8s Gen 4 Mobile Platform, delivering high processing performance and smooth operation. In addition, a large-capacity 5,100 mAh battery and newly designed heat-dissipation components enable stable, long-duration enjoyment of activities such as video streaming and gaming.
Outstanding Features
1. AI-powered camera features, from automatic zoom adjustment to enhanced privacy protection2. Equipped with Akarium, a feature that creates a comfortable atmosphere through light and sound3. Enhanced peak brightness and automatic correction of low-tone areas ensure clear visibility and a comfortable viewing experience, even under strong sunlight or in dim outdoor conditions
Product name: Smartphone
Brand name: AQUOS R11
Release date (Japan): On and after July 9, 2026 (*1)
*1 The release date may vary depending on the carrier.*2 Prior setup is required.*3 Detection results may vary depending on the subject and shooting conditions.
Outstanding Features
1. AI-powered camera features, from automatic zoom adjustment to enhanced privacy protection
The newly introduced Smart Fit Zoom allows users to simply tap a dedicated icon, enabling AI to automatically adjust the zoom level according to the subject and capture well-balanced compositions focused on the intended subject. In addition, the Privacy Safe feature automatically detects and masks text such as signs and billboards at the time of capture, helping protect privacy when sharing images on social media. Furthermore, when photographing a My Number Card for identity verification, fields such as gender and organ donor consent are also automatically masked.
In addition, when taking group photos, the camera can generate a single image in which everyone's eyes are naturally open by combining multiple shots. When capturing documents, it removes shadows and corrects perspective distortion, ensuring that text remains clear and easy to read.
2. Equipped with Akarium, a feature that creates a comfortable atmosphere through light and sound
The new Akarium feature uses a light positioned at the center of the rear camera ring to gently notify users of incoming calls, messages, and other alerts. The lighting incorporates eight colors inspired by hues found in nature. In addition, under the supervision of sound designer Shinya Kiyokawa, healing sounds recorded from nature are synchronized with lighting effects inspired by elements such as a campfire, a flowing stream, and sunlight filtering through trees, creating a relaxing and comfortable atmosphere for moments like before bedtime or during breaks.
The device design was supervised by miyake design, founded by designer Kazushige Miyake. The camera ring retains its distinctive free-curve form-neither a perfect circle nor a square. Featuring glossy glass materials and a gently rounded form, the design fits comfortably in the hand while delivering a simple yet premium feel. The lineup includes three distinctive color options that highlight individual style.
3. Enhanced peak brightness and automatic correction of low-tone areas ensure clear visibility and a comfortable viewing experience, even under strong sunlight or in dim outdoor conditions
The approximately 6.5-inch Pro IGZO OLED display has been enhanced to achieve a peak brightness of 3,600 nits-1.2 times higher than the previous model (*4). With Smart Outdoor View, low-tone areas are automatically brightened according to ambient lighting conditions, suppressing black crush and ensuring that details remain clearly visible. In addition, the bezels surrounding the display have been reduced by approximately 21.7 %, achieving a large-screen experience while maintaining a comfortable, easy-to-hold form factor. On the audio side, Dolby Atmos(R)-compatible full-metal BOX speakers deliver immersive sound, from deep bass to clear high sound range.
The device is powered by the Snapdragon(R) 8s Gen 4 Mobile Platform, achieving performance improvements over the previous model of approximately 13 % in CPU and approximately 40 % in GPU (*4). Combined with an enlarged vapor chamber heat dissipation system and the series' largest 5,100 mAh battery, the device maintains stable performance even during demanding gameplay, enabling comfortable use over extended periods.
*4 Compared with the 2025 model AQUOS R10.
Other Features
Equipped with the AI-powered Vocalist feature that eliminates noise in real time. By registering your voice in advance, the AI can identify and suppress voices other than your own as well as surrounding noise during calls, allowing only your voice to be transmitted to the other party. This enables clear and comfortable communication without concern for location, even in environments with loud background noise or announcements.
Corning(R) Gorilla(R) Glass Victus(R) 2 is used on both the front and rear, delivering high durability with enhanced resistance to drops. In addition to a design compliant with MIL standards (*5), the device offers dust resistance and IP69-rated water resistance (*6), ensuring comfortable use across a wide range of scenarios, from everyday settings to outdoor environments.
A new Home Deco feature (*2) enables users to customize wallpapers and fonts to create a home screen tailored to their personal preferences. In addition, Lock Photo Shuffle uses AI to automatically select and display recommended photos from the device on the lock screen, allowing users to enjoy their memories each time they check their display.
As an optional accessory to further enhance the enjoyment of Akarium, Sharp has collaborated with the smartphone accessory brand temari (*7). The lineup includes three colors inspired by a campfire, a flowing stream, and sunlight filtering through trees. By placing this accessory over the rear camera ring, the light is diffused randomly, expanding the range of ambient lighting effects.
*5 Testing has been conducted in accordance with impact (drop) resistance standards based on the U.S. Department of Defense procurement criteria (MIL-STD-810G). The performance of this product has been verified under test conditions and does not guarantee the operation of all functions under all actual usage conditions. Furthermore, it does not guarantee that the device will remain free from damage or malfunction under all impact conditions.
*6 Testing has been conducted in accordance with 15 items of the U.S. Department of Defense procurement standard (MIL-STD-810H), including water resistance (immersion), water resistance (rain), vibration resistance, humidity resistance, high-temperature storage (fixed), high-temperature storage (cyclic), high-temperature operation (fixed), high-temperature operation (cyclic), low-temperature operation, low-temperature storage, temperature durability (thermal shock), low-pressure storage, low-pressure operation, icing (condensation), and icing (freezing).The performance of this product has been verified under test conditions and does not guarantee the operation of all functions under all actual usage conditions. Furthermore, it does not guarantee that the device will remain free from damage or malfunction under all impact conditions.
*7 Sales of the accessory will be handled by IRIS Co., Ltd. (Head office: Ota City, Gunma Prefecture; President: Kogoro Osumi). For details, please visit the company's website: https://iris-pro.com/all/aquos-r1xtemari/ (in Japanese).
*8 35 mm conversion.
*9 Actual usable battery capacity may vary.
- AQUOS, the AQUOS logo, and the AQUOS R logo are trademarks or registered trademarks of Sharp Corporation.
- Osaifu-Keitai is a registered trademark of NTT Docomo, Inc.
- Google, Android, and related logos and marks are trademarks of Google LLC.
- Snapdragon is a product of Qualcomm Technologies, Inc. and/or its subsidiaries.Snapdragon is a trademark or registered trademark of Qualcomm Incorporated.
- Dolby, Dolby Atmos, and the double-D symbol are registered trademarks of Dolby Laboratories, Inc.
- Other product names and brand names may be trademarks or registered trademarks of their respective owners.
Information on this product is also available on the following website:https://jp.sharp/k-tai/ (in Japanese)
About Sharp
For more than 110 years, Sharp Corporation has been developing pioneering, world-first and industry-first products and technologies primarily in electronics. Based on its business creed "Sincerity and Creativity" the company has established its corporate slogan "In step with your future." and aims to create New Cultures through innovative products and services in every aspect of how people live and work.
For more information, please visit: https://global.sharp/
Source: Sharp Corporation
Copyright 2026 JCN Newswire . All rights reserved.
MIAMI--(BUSINESS WIRE)--Ryder System, Inc. (NYSE: R) today announced the winners of its 54th annual Driver of the Year award, recognizing three professional drivers whose commitment to excellence in safety, customer service, and leadership exemplifies the best of Ryder’s operations across its supply chain, dedicated transportation, and fleet management businesses.
“Ryder professional drivers do far more than deliver freight — they set the standard for how our company shows up every day.”
Share The honorees—Tamara “Tammy” Land, Robert Deroy, and Terry Frey—bring decades of combined experience and millions of safe miles to the road. Each has earned a reputation for excellence behind the wheel and for the positive impact they make on customers, teammates, and the communities they serve. As part of this honor, all three drivers are inducted into the Ryder Driver Hall of Fame.
“Ryder professional drivers do far more than deliver freight — they set the standard for how our company shows up every day,” said Ryder CEO John Diez. “Tammy, Robert, and Terry embody what it means to lead with professionalism, put safety first, and take pride in serving others. Their dedication reflects the strength of our culture and the trust our customers place in Ryder.”
Tammy Land | Supply Chain Solutions
Based in Waterloo, Iowa, Tammy Land is Ryder’s Supply Chain Solutions Driver of the Year, bringing more than 32 years of professional driving experience, including five years with Ryder. Over her career, she has logged more than 2.2 million miles, including 415,000 miles driven with Ryder, while maintaining an exceptional safety record.
A Ryder Certified Driver Trainer, and known for her steady leadership and proactive communication, Land plays a key role in mentoring new drivers and reinforcing Ryder’s safety culture from day one. Beyond her work, Land is actively involved in community and volunteer efforts, including wildlife rehabilitation and breast cancer awareness.
Robert Deroy | Dedicated Transportation Solutions
Supporting a Ryder customer out of West Palm Beach, Fla., Robert Deroy is the Dedicated Transportation Solutions Driver of the Year, bringing 25 years of professional driving experience, including 15 years with Ryder. Since joining the company in 2010, Deroy has logged nearly 1.3 million miles with Ryder and nearly 2.2 million miles over his career, distinguishing himself as a leader in safety, training, and operational excellence.
A long‑standing Certified Driver Trainer, Smith System Trainer, and American Red Cross CPR, AED, and First Aid instructor, Deroy is known for being one of Ryder’s most trusted drivers in high‑stakes, safety‑critical situations and specialized operations. In his spare time, he is deeply engaged in community support activities, including emergency response and disaster‑relief efforts.
Terry Frey | Fleet Management Solutions
Operating out of Conestoga, Penn., Terry Frey is the recipient of Ryder’s Fleet Management Solutions Driver of the Year award, which recognizes customer drivers who go above and beyond to keep roads safe while operating Ryder vehicles. Frey brings 34 years of professional driving experience, including more than 26 years supporting a Ryder‑managed fleet for Turkey Hill Dairy. Over his career, he has logged nearly 2.5 million miles, including more than 2 million miles at Turkey Hill Dairy.
Known for his reliability, professionalism, and attention to detail, Frey is widely respected by Ryder technicians, customer teams, and fellow drivers. Beyond his work, Frey is deeply involved in his local community, where he has spent years mentoring young people and supporting nonprofit organizations focused on youth development and character building.
About Ryder System, Inc.
Ryder System, Inc. (NYSE: R) is a nearly $13 billion leading provider of outsourced logistics and transportation services throughout the United States, Canada, and Mexico. Ryder offers supply chain, dedicated transportation, and fleet management solutions that integrate every step of the supply chain port‑to‑door, including cross-border logistics, fleet and transportation management, warehousing and distribution, and final delivery to customers’ doorsteps. Ryder’s broad portfolio of services encompasses managed transportation, freight brokerage, dedicated contract carriage with professional drivers, full‑service fleet leasing and maintenance, commercial truck rental, automation and robotics, digital technologies, contract manufacturing and packaging, omnichannel retail fulfillment including e-commerce and last-mile delivery, and used vehicle sales. Serving more than 20 industries, Ryder manages approximately 240,000 commercial vehicles, operates nearly 800 maintenance locations, and runs approximately 320 warehouses totaling more than 100 million square feet. Ryder is consistently recognized for technology‑driven innovation and industry‑leading practices in safety, health, security, talent acquisition, and environmental management, and was most recently named to Fortune’s “America’s Most Innovative Companies” list. www.ryder.com
Note Regarding Forward-Looking Statements: Certain statements and information included in this news release are “forward-looking statements” within the meaning of the Federal Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on our current plans and expectations and are subject to risks, uncertainties and assumptions. Accordingly, these forward-looking statements should be evaluated with consideration given to the many risks and uncertainties that could cause actual results and events to differ materially from those in the forward-looking statements including those risks set forth in our periodic filings with the Securities and Exchange Commission. New risks emerge from time to time. It is not possible for management to predict all such risk factors or to assess the impact of such risks on our business. Accordingly, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.
Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, growth, and momentum to find strong companies for our readers.
Of these, value investing is easily one of the most popular ways to find great stocks in any market environment. Value investors use a variety of methods, including tried-and-true valuation metrics, to find these stocks.
Luckily, Zacks has developed its own Style Scores system in an effort to find stocks with specific traits. Value investors will be interested in the system's "Value" category. Stocks with both "A" grades in the Value category and high Zacks Ranks are among the strongest value stocks on the market right now.
Ryder System (R - Free Report) is a stock many investors are watching right now. R is currently holding a Zacks Rank #2 (Buy) and a Value grade of A. The stock is trading with P/E ratio of 12.74 right now. For comparison, its industry sports an average P/E of 16.25. Over the past 52 weeks, R's Forward P/E has been as high as 13.18 and as low as 9.22, with a median of 11.32.
We should also highlight that R has a P/B ratio of 2.44. The P/B ratio pits a stock's market value against its book value, which is defined as total assets minus total liabilities. This company's current P/B looks solid when compared to its industry's average P/B of 3.71. Over the past 12 months, R's P/B has been as high as 2.52 and as low as 1.79, with a median of 2.16.
Value investors also love the P/S ratio, which is calculated by simply dividing a stock's price with the company's sales. Some people prefer this metric because sales are harder to manipulate on an income statement. This means it could be a truer performance indicator. R has a P/S ratio of 0.84. This compares to its industry's average P/S of 1.35.
These are only a few of the key metrics included in Ryder System's strong Value grade, but they help show that the stock is likely undervalued right now. When factoring in the strength of its earnings outlook, R looks like an impressive value stock at the moment.
Inclusion reflects the growing convergence of loyalty, promotions, rewards, and first-party customer intelligence in the modern customer engagement landscape
VANCOUVER, BC / ACCESS Newswire / June 17, 2026 / Snipp Interactive Inc. ("Snipp" or the "Company") (TSX-V:SPN)(OTCPK:SNIPF), a value-added SaaS company and leader in shopper marketing promotions, loyalty programs, and purchase validation technology, today announced it has been named a Representative Vendor in the Gartner® 2026 Market Guide for Loyalty Program Vendors in the Multisolution Vendor category. This inclusion places Snipp among vendors included in the report and underscores the company's growing presence at the intersection of loyalty, promotions, and data-driven customer engagement.
The Gartner Market Guide evaluates vendors across the loyalty technology landscape, identifying providers that serve enterprise brands seeking integrated solutions for customer acquisition, engagement, and retention. Snipp's inclusion in the Multisolution Vendor category reflects the breadth of its AI powered platform capabilities, spanning loyalty program management, promotional marketing, receipt-based purchase validation, rebate processing, rewards fulfillment, sweepstakes, and customer intelligence.
"We are proud to be listed in Gartner's 2026 Market Guide for Loyalty Program Vendors," said Atul Sabharwal, Founder and CEO of Snipp. "There is a growing demand by brands for a strong multi-solution technology partner who can connect loyalty, promotions, rewards, and customer intelligence into a unified ecosystem. This inclusion reflects exactly that demand, and we're proud to be acknowledged as a vendor meeting it."
A Unified Platform for a More Complex Customer Engagement Landscape
The Gartner report notes that loyalty programs are evolving beyond traditional retention initiatives and increasingly serve as a mechanism for collecting customer data, enabling personalization, and driving long-term customer value. Mid-to-large brands across CPG, retail, and food and beverage are facing mounting pressure to do more with customer data while managing fragmented technology stacks that keep loyalty, promotions, and purchase insights siloed from one another. Snipp's platform addresses this directly by connecting verified transactional data, first-party data acquisition, and program management within a single ecosystem.
At the core of Snipp's differentiation is its AI-powered receipt processing and purchase validation technology, which enables brands to capture verified purchase behavior at scale, independent of retailer data sharing agreements. Combined with fraud detection and prevention capabilities, rewards management, and configurable loyalty mechanics, the platform gives brands a complete infrastructure for managing customer relationships from initial acquisition through long-term retention.
Inclusion That Reflects Market Direction
Snipp's inclusion in the Gartner 2026 Market Guide validates what the company and its customers have seen in practice: loyalty programs are no longer standalone engagement mechanics. They are becoming strategic customer intelligence platforms, and vendors that can integrate promotions, purchase verification, rewards, and actionable data insights within a single offering are best positioned to deliver measurable business outcomes for the brands they serve.
Snipp serves leading brands across CPG, retail, food and beverage, and other consumer industries globally, supporting loyalty programs, rebate campaigns, promotional activations, and data capture initiatives through a single platform and partner relationship.
Learn More about Snipp loyalty https://www.snipp.com/customer-loyalty-platform
About Snipp
Snipp Interactive Inc. (TSX-V: SPN; OTCPK: SNIPF) is a leading AI-powered technology provider in the global loyalty and promotions sector. Snipp helps brands drive actions, prove performance, and unlock insights across consumer and channel marketing strategies by connecting promotions, sweepstakes, offers, rebates, rewards, loyalty, and media programs directly to verified purchases.
Snipp's modular platform enables Fortune 500 brands, agencies, and partners to run both short-term and always-on programs at scale, transforming engagement into proven outcomes and owned first-party intelligence that powers meaningful, measurable growth. Snipp's AI-powered receipt and transaction validation capabilities have become an industry standard, enabling accurate, retailer-agnostic measurement.
Snipp is headquartered in Vancouver, Canada with a presence across the United States, Canada, Ireland, Europe, and India. Snipp is publicly listed on the TSX Venture Exchange in Canada and is also quoted on the OTC Pink marketplace under the symbol SNIPF. For more information, visit Snipp's website at www.snipp.com and its profile on SEDAR+ at www.sedarplus.ca.
Gartner®, Market Guide for Loyalty Program Vendors, May 2026. Gartner does not endorse any vendor, product or service depicted in its research publications and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
This press release contains forward-looking statements that involve risks and uncertainties, which may cause actual results to differ materially from the statements made. When used in this document, the words "may", "would", "could", "will", "intend", "plan", "anticipate", "believe", "estimate", "expect" and similar expressions are intended to identify forward-looking statements. Such statements reflect our current views with respect to future events and are subject to such risks and uncertainties. Many factors could cause our actual results to differ materially from the statements made, including those factors discussed in filings made by us with the Canadian securities regulatory authorities. Should one or more of these risks and uncertainties, such as changes in demand for and prices for the products of the company or the materials required to produce those products, labour relations problems, currency and interest rate fluctuations, increased competition and general economic and market factors, occur or should assumptions underlying the forward looking statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, or expected. We do not intend and do not assume any obligation to update these forward-looking statements, except as required by law. The reader is cautioned not to put undue reliance on such forward-looking statements.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Copyright Snipp Interactive Inc. All rights reserved. All other trademarks and trade names are the property of their respective owners.
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving that way. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.
While many investors like to look for momentum in stocks, this can be very tough to define. There is a lot of debate surrounding which metrics are the best to focus on and which are poor quality indicators of future performance. The Zacks Momentum Style Score, part of the Zacks Style Scores, helps address this issue for us.
Below, we take a look at Ryder (R - Free Report) , a company that currently holds a Momentum Style Score of B. We also talk about price change and earnings estimate revisions, two of the main aspects of the Momentum Style Score.
It's also important to note that Style Scores work as a complement to the Zacks Rank, our stock rating system that has an impressive track record of outperformance. Ryder currently has a Zacks Rank of #2 (Buy). Our research shows that stocks rated Zacks Rank #1 (Strong Buy) and #2 (Buy) and Style Scores of "A or B" outperform the market over the following one-month period.
You can see the current list of Zacks #1 Rank Stocks here >>>
Set to Beat the Market? In order to see if R is a promising momentum pick, let's examine some Momentum Style elements to see if this truck leasing company holds up.
Looking at a stock's short-term price activity is a great way to gauge if it has momentum, since this can reflect both the current interest in a stock and if buyers or sellers have the upper hand at the moment. It's also helpful to compare a security to its industry; this can show investors the best companies in a particular area.
For R, shares are up 5.7% over the past week while the Zacks Transportation - Equipment and Leasing industry is up 2.23% over the same time period. Shares are looking quite well from a longer time frame too, as the monthly price change of 10.45% compares favorably with the industry's 2.46% performance as well.
While any stock can see its price increase, it takes a real winner to consistently beat the market. That is why looking at longer term price metrics -- such as performance over the past three months or year -- can be useful as well. Over the past quarter, shares of Ryder have risen 31.76%, and are up 73.85% in the last year. On the other hand, the S&P 500 has only moved 13.47% and 26.67%, respectively.
Investors should also pay attention to R's average 20-day trading volume. Volume is a useful item in many ways, and the 20-day average establishes a good price-to-volume baseline; a rising stock with above average volume is generally a bullish sign, whereas a declining stock on above average volume is typically bearish. R is currently averaging 394,337 shares for the last 20 days.
Earnings OutlookThe Zacks Momentum Style Score encompasses many things, including estimate revisions and a stock's price movement. Investors should note that earnings estimates are also significant to the Zacks Rank, and a nice path here can be promising. We have recently been noticing this with R.
Over the past two months, 2 earnings estimates moved higher compared to none lower for the full year. These revisions helped boost R's consensus estimate, increasing from $14.23 to $14.82 in the past 60 days. Looking at the next fiscal year, 2 estimates have moved upwards while there have been no downward revisions in the same time period.
Bottom LineTaking into account all of these elements, it should come as no surprise that R is a #2 (Buy) stock with a Momentum Score of B. If you've been searching for a fresh pick that's set to rise in the near-term, make sure to keep Ryder on your short list.
June 18, 2026 08:00 ET | Source: Denali Therapeutics Inc.
Proceeds from transaction to support advancement of Denali’s broad TransportVehicle™-enabled clinical portfolio for lysosomal storage disorders and neurodegenerative diseasesDenali was awarded Priority Review Voucher following FDA approval of AVLAYAH™, the first FDA-approved biologic specifically designed to cross blood-brain barrier SOUTH SAN FRANCISCO, Calif., June 18, 2026 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI) today announced it has entered into a definitive agreement to sell its Rare Pediatric Disease Priority Review Voucher (PRV) for gross proceeds of $195 million. The U.S. Food and Drug Administration (FDA) awarded the PRV to Denali following accelerated approval of the enzyme replacement therapy AVLAYAH™ (tividenofusp alfa-eknm) for the treatment of Hunter syndrome (mucopolysaccharidosis type II; MPS II) in March 2026. AVLAYAH is the first FDA-approved medicine in an emerging class of biotherapeutics designed to cross the blood-brain barrier via transferrin receptor (TfR)-mediated transport.
"The Priority Review Voucher program is an important and effective mechanism to support the development of medicines for rare pediatric diseases. Monetizing this PRV strengthens our financial flexibility at a pivotal moment as we build on the momentum created by the FDA approval of AVLAYAH, the first FDA-approved biotherapeutic designed to reach the whole body, including the brain," said Alexander Schuth, M.D., Chief Operating and Financial Officer of Denali Therapeutics. "The proceeds will fuel the advancement and acceleration of our broad clinical pipeline, including additional Enzyme TransportVehicle programs for lysosomal storage disorders and Oligonucleotide and Antibody TransportVehicle programs targeting Alzheimer's and other neurodegenerative diseases."
Denali's clinical-stage portfolio includes DNL126 (ETV:SGSH) for Sanfilippo syndrome type A (MPS IIIA), DNL593 (PTV:PGRN) for GRN-related frontotemporal dementia, DNL952 (ETV:GAA) for Pompe disease and DNL628 (OTV:MAPT) for Alzheimer's disease. Denali also has multiple programs in the Investigational New Drug (IND)-enabling stage, including DNL921 (ATV:Abeta) for Alzheimer's disease, DNL111 (ETV:GCase) for Parkinson's disease and Gaucher disease, DNL622 (ETV:IDUA) for Hurler syndrome (MPS I) and DNL422 (OTV:SNCA) for Parkinson's disease.
The PRV transaction is subject to customary closing conditions, including expiration of the applicable waiting period under the Hart-Scott Rodino Antitrust Improvements Act.
About the Denali TransportVehicle™ Platform
The blood-brain barrier (BBB) is essential in maintaining the brain’s microenvironment and protecting it from harmful substances and pathogens circulating in the bloodstream. Historically, the BBB has posed significant challenges to drug development for central nervous system diseases by preventing most drugs from reaching the brain in therapeutically relevant concentrations. Denali’s TransportVehicle™ (TV) platform is a proprietary technology designed to effectively deliver large therapeutic molecules such as antibodies, enzymes and oligonucleotides throughout the whole body, including the brain, by crossing the BBB after intravenous administration. The TV platform is based on engineered Fc domains that bind to specific natural transport receptors, such as transferrin receptor and CD98 heavy chain amino acid transporter, which are expressed at the BBB and deliver the TV and its therapeutic cargo to the brain through receptor-mediated transcytosis. In animal models, antibodies and enzymes engineered with the TV platform demonstrate more than 10- to 30-fold greater brain exposure than similar antibodies and enzymes without this technology. Oligonucleotides engineered with the TV platform demonstrate more than a 1,000-fold greater brain exposure in primates than systemically delivered oligonucleotides without this technology. Improved exposure and broad distribution in the brain may increase therapeutic efficacy by enabling widespread achievement of therapeutically relevant concentrations of product candidates. The TV platform has been clinically validated, with AVLAYAH™ (tividenofusp alfa-eknm) as the first FDA-approved medicine leveraging transferrin receptor to cross the BBB.
About Denali Therapeutics
Denali Therapeutics Inc. is a biotechnology company pioneering a new class of biotherapeutics designed to cross the blood-brain barrier (BBB) using its proprietary TransportVehicle™ platform. With the first FDA-approved biologic specifically designed to cross the BBB, a clinically validated delivery platform and a growing portfolio of therapeutic candidates across all stages of development, Denali is advancing toward its goal of delivering effective medicines to transform life for people with neurodegenerative diseases, lysosomal storage disorders and other serious diseases. For more information, please visit www.denalitherapeutics.com.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements expressed or implied in this press release include, but are not limited to, statements regarding the timeline and likelihood of satisfying closing conditions for, and consummating the sale of, the Priority Review Voucher (“PRV”); expected use of proceeds from the sale of the PRV and the anticipated impact on Denali's cash runway; plans, timelines and expectations related to Denali's Enzyme TransportVehicle™ (ETV) franchise and its therapeutic and commercial potential; plans, timelines and expectations related to AVLAYAH™ (tividenofusp alfa-eknm); and statements by Denali’s Chief Operating and Financial Officer. Actual results may differ materially from those expressed or implied by these forward-looking statements due to a variety of risks and uncertainties. These include, but are not limited to, uncertainties related to the FDA’s policies and accelerated approval program; risks arising from adverse economic conditions and their impact on Denali’s business and operations; the possibility of events or changes that could lead to the termination of Denali’s collaboration agreements; challenges associated with Denali’s transition to a commercial company; the ability of Denali and its collaborators to complete the development and, if approved, the commercialization of product candidates; difficulties in patient enrollment for ongoing and future clinical trials; whether the current ongoing trials have been powered sufficiently to demonstrate approvability to regulatory agencies; reliance on third-party manufacturers and suppliers for clinical trial materials; dependence on the successful development of Denali’s blood-brain barrier platform technology and related programs; potential delays or failures in meeting expected clinical trial timelines; the risk that promising preclinical profiles may not be replicated in clinical settings; discrepancies between preclinical, early-stage or preliminary clinical results and outcomes from later-stage trials; the occurrence of significant adverse events or other undesirable side effects; the uncertainty surrounding regulatory approvals required for commercialization in the U.S., Europe or other international jurisdictions; Denali’s ability to advance a pipeline of product candidates or develop commercially successful products; developments relating to Denali's competitors and its industry, including competing product candidates and therapies; Denali’s ability to obtain, maintain or protect intellectual property rights related to its product candidates; the implementation and success of Denali’s strategic plans for its business, product candidates and blood-brain barrier platform technology; Denali's ability to obtain additional capital to finance its operations, as needed; Denali's ability to accurately forecast future financial results in the current environment; and other risks and uncertainties, including those described in Denali's most recent Annual and Quarterly Reports on Forms 10-K and 10-Q filed with the Securities and Exchange Commission (SEC) on February 26, 2026 and May 7, 2026, respectively, and Denali’s future reports to be filed with the SEC. Except for AVLAYAH, Denali's product candidates are investigational, and their safety and efficacy profiles have not yet been established. Denali does not undertake any obligation to update or revise any forward-looking statements, to conform these statements to actual results or to make changes in Denali’s expectations, except as required by law.
Key Takeaways DNLI signed a definitive agreement to sell its Rare Pediatric Disease PRV for $195M in gross proceeds.The PRV was awarded after FDA accelerated approval of Avlayah for Hunter syndrome in March 2026.DNLI said the non-dilutive funding will help advance its clinical portfolio in key disease areas. Denali Therapeutics Inc. (DNLI - Free Report) announced that it has entered into a definitive agreement to sell its Rare Pediatric Disease Priority Review Voucher (“PRV”).
The sale will generate gross proceeds of $195 million.
The PRV was granted to DNLI following the FDA accelerated approval of Avlayah (tividenofusp alfa-eknm) in March 2026 for the treatment of Hunter syndrome (mucopolysaccharidosis type II, or MPS II).
The transaction provides a significant non-dilutive capital infusion, strengthening the company’s balance sheet without requiring an equity raise. The added financial flexibility will help advance Denali’s broad TransportVehicle-enabled clinical portfolio for lysosomal storage disorders and neurodegenerative diseases.
The PRV sale remains subject to customary closing conditions, including the expiration or termination of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act.
Shares of DNLI have gained 41.2% year to date against the industry’s 1.7% decline.
Image Source: Zacks Investment Research
More on DNLI’s AvlayahAvlayah is the first FDA-approved therapy based on an emerging of biotherapeutics designed to cross the blood-brain barrier using transferrin receptor (TfR)-mediated transport technology.
The approval for Avlayah has significantly boosted DNLI’s growth prospects.
Denali's clinical-stage portfolio includes DNL126 for Sanfilippo syndrome type A (MPS IIIA), DNL593 for GRN-related frontotemporal dementia, DNL952 for Pompe disease and DNL628 for Alzheimer's disease.
Denali is also advancing several early-stage pipeline candidates, including DNL921 for Alzheimer's disease, DNL111 for Parkinson’s and Gaucher diseases, DNL622 for Hurler syndrome (MPS I), and DNL422 (OTV) for Parkinson’s disease.
Denali has also collaborated with other pharma and biotech giants like Sanofi (SNY - Free Report) , Biogen (BIIB - Free Report) and Takeda (TAK - Free Report) to develop other candidates.
Last month, Denali and partner Biogen announced disappointing top-line results from a mid-stage study evaluating BIIB122 (DNL151) in individuals with early-stage Parkinson’s disease.
The study did not meet its primary or secondary endpoints.
Consequently, Biogen and Denali have discontinued the development of BIIB122 in idiopathic Parkinson’s disease.
Nonetheless, Denali will continue independently advancing the phase IIa BEACON study on evaluating the small molecule inhibitor in patients carrying pathogenic LRRK2 variants.
Partner Sanofi is developing eclitasertib for moderate to severe ulcerative colitis.
In April 2026, Denali announced that partner Takeda decided to terminate their collaboration for DNL593 (PTV:PGRN) in frontotemporal dementia associated with GRN mutations (FTD-GRN).
The termination, effective 60 days after notice, returns full rights to the program to Denali. Per DNLI, Takeda’s decision was based on strategic priorities and not on any efficacy or safety issues.
The company’s sound cash position is a positive and underscores its ability to fund ongoing programs.
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.
Zacks Premium also includes the Zacks Style Scores.
What are the Zacks Style Scores? Developed alongside the Zacks Rank, the Zacks Style Scores are a group of complementary indicators that help investors pick stocks with the best chances of beating the market over the next 30 days.
Each stock is assigned a rating of A, B, C, D, or F based on their value, growth, and momentum characteristics. Just like in school, an A is better than a B, a B is better than a C, and so on -- that means the better the score, the better chance the stock will outperform.
The Style Scores are broken down into four categories:
Value ScoreFinding good stocks at good prices, and discovering which companies are trading under their true value, are what value investors like to focus on. So, the Value Style Score takes into account ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and a host of other multiples to highlight the most attractive and discounted stocks.
Growth ScoreGrowth investors, on the other hand, are more concerned with a company's financial strength and health, and its future outlook. The Growth Style Score examines things like projected and historic earnings, sales, and cash flow to find stocks that will experience sustainable growth over time.
Momentum ScoreMomentum investors, who live by the saying "the trend is your friend," are most interested in taking advantage of upward or downward trends in a stock's price or earnings outlook. Utilizing one-week price change and the monthly percentage change in earnings estimates, among other factors, the Momentum Style Score can help determine favorable times to buy high-momentum stocks.
VGM ScoreWhat if you like to use all three types of investing? The VGM Score is a combination of all Style Scores, making it one of the most comprehensive indicators to use with the Zacks Rank. It rates each stock on their combined weighted styles, which helps narrow down the companies with the most attractive value, best growth forecast, and most promising momentum.
How Style Scores Work with the Zacks Rank The Zacks Rank is a proprietary stock-rating model that harnesses the power of earnings estimate revisions, or changes to a company's earnings expectations, to help investors build a successful portfolio.
#1 (Strong Buy) stocks have produced an unmatched +24% average annual return since 1988, which is more than double the S&P 500's performance over the same time frame. However, the Zacks Rank examines a ton of stocks, and there can be more than 200 companies with a Strong Buy rank, and another 600 with a #2 (Buy) rank, on any given day.
This totals more than 800 top-rated stocks, and it can be overwhelming to try and pick the best stocks for you and your portfolio.
That's where the Style Scores come in.
To maximize your returns, you want to buy stocks with the highest probability of success. This means picking stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you find yourself looking at stocks with a #3 (Hold) rank, make sure they have Scores of A or B as well to ensure as much upside potential as possible.
Since the Scores were created to work together with the Zacks Rank, the direction of a stock's earnings estimate revisions should be a key factor when choosing which stocks to buy.
Here's an example: a stock with a #4 (Sell) or #5 (Strong Sell) rating, even one with Style Scores of A and B, still has a downward-trending earnings outlook, and a bigger chance its share price will decrease too.
Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.
Stock to Watch: Teradata (TDC - Free Report) Teradata offers an open and connected hybrid cloud analytics and data platform for AI. The hybrid cloud platform, named Teradata Vantage, help enterprises solve business problems with Teradata’s capabilities to provide harmonized data, trusted AI, and faster innovation, at scale.
TDC is a #2 (Buy) on the Zacks Rank, with a VGM Score of A.
Additionally, the company could be a top pick for growth investors. TDC has a Growth Style Score of A, forecasting year-over-year earnings growth of 2.7% for the current fiscal year.
Two analysts revised their earnings estimate higher in the last 60 days for fiscal 2026, while the Zacks Consensus Estimate has increased $0.04 to $2.65 per share. TDC also boasts an average earnings surprise of +24.8%.
With a solid Zacks Rank and top-tier Growth and VGM Style Scores, TDC should be on investors' short list.
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.
The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens.
Zacks Premium also includes the Zacks Style Scores.
What are the Zacks Style Scores? The Zacks Style Scores is a unique set of guidelines that rates stocks based on three popular investing types, and were developed as complementary indicators for the Zacks Rank. This combination helps investors choose securities with the highest chances of beating the market over the next 30 days.
Each stock is given an alphabetic rating of A, B, C, D or F based on their value, growth, and momentum qualities. With this system, an A is better than a B, a B is better than a C, and so on, meaning the better the score, the better chance the stock will outperform.
The Style Scores are broken down into four categories:
Value ScoreFinding good stocks at good prices, and discovering which companies are trading under their true value, are what value investors like to focus on. So, the Value Style Score takes into account ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and a host of other multiples to highlight the most attractive and discounted stocks.
Growth ScoreGrowth investors are more concerned with a stock's future prospects, and the overall financial health and strength of a company. Thus, the Growth Style Score analyzes characteristics like projected and historic earnings, sales, and cash flow to find stocks that will see sustainable growth over time.
Momentum ScoreMomentum investors, who live by the saying "the trend is your friend," are most interested in taking advantage of upward or downward trends in a stock's price or earnings outlook. Utilizing one-week price change and the monthly percentage change in earnings estimates, among other factors, the Momentum Style Score can help determine favorable times to buy high-momentum stocks.
VGM ScoreWhat if you like to use all three types of investing? The VGM Score is a combination of all Style Scores, making it one of the most comprehensive indicators to use with the Zacks Rank. It rates each stock on their combined weighted styles, which helps narrow down the companies with the most attractive value, best growth forecast, and most promising momentum.
How Style Scores Work with the Zacks Rank The Zacks Rank is a proprietary stock-rating model that harnesses the power of earnings estimate revisions, or changes to a company's earnings expectations, to help investors build a successful portfolio.
#1 (Strong Buy) stocks have produced an unmatched +24% average annual return since 1988, which is more than double the S&P 500's performance over the same time frame. However, the Zacks Rank examines a ton of stocks, and there can be more than 200 companies with a Strong Buy rank, and another 600 with a #2 (Buy) rank, on any given day.
With more than 800 top-rated stocks to choose from, it can certainly feel overwhelming to pick the ones that are right for you and your investing journey.
That's where the Style Scores come in.
You want to make sure you're buying stocks with the highest likelihood of success, and to do that, you'll need to pick stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you like a stock that only has a #3 (Hold) rank, it should also have Scores of A or B to guarantee as much upside potential as possible.
The direction of a stock's earnings estimate revisions should always be a key factor when choosing which stocks to buy, since the Scores were created to work together with the Zacks Rank.
A stock with a #4 (Sell) or #5 (Strong Sell) rating, for instance, even one with Scores of A and B, will still have a declining earnings forecast, and a greater chance its share price will fall too.
Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.
Stock to Watch: Teradata (TDC - Free Report) Teradata offers an open and connected hybrid cloud analytics and data platform for AI. The hybrid cloud platform, named Teradata Vantage, help enterprises solve business problems with Teradata’s capabilities to provide harmonized data, trusted AI, and faster innovation, at scale.
TDC is a #3 (Hold) on the Zacks Rank, with a VGM Score of A.
It also boasts a Value Style Score of B thanks to attractive valuation metrics like a forward P/E ratio of 11.99; value investors should take notice.
For fiscal 2026, two analysts revised their earnings estimate upwards in the last 60 days, and the Zacks Consensus Estimate has increased $0.04 to $2.65 per share. TDC boasts an average earnings surprise of +24.8%.
With a solid Zacks Rank and top-tier Value and VGM Style Scores, TDC should be on investors' short list.
The equity has consistently realized higher-than-expected volatility
Assistant Editor
Jun 17, 2026 at 3:18 PM
The defense tech firm will report earnings after the close on Monday, June 29
AeroVironment, Inc. (NASDAQ:AVAV) will report fiscal fourth-quarter earnings after the market closes on Monday, June 29. According to Zacks Research, analysts expect profits of $1.53 per share on revenue of $563.1 million.
In terms of earnings history, AVAV has closed only two of its last eight next-day sessions higher, including a 12.9% drop in December. Options traders are bracing for a larger-than-usual post-earnings reaction, pricing in a next-day swing of 13.8%, compared to the stock's average move of 10.1% over the last eight quarters.
On the charts, the defense stock is sitting hovering near its 52-week lows, despite a recent rebound attempt off the $160 floor. This mark was a level of support during AVAV's mid-May pullback. So far in 2026, the equity has shed 29%.
Short interest has been inching higher, now representing 12.07% of AVAV's available float. At the stock's average pace of trading, it would take over three days to buy back the 4.61 million shares sold short.
At the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), AeroVironment stock's 10-day call/put volume ratio of 4.85 ranks in the 90th annual percentile. Echoing this is the stock's Schaeffer's put/call open interest ratio (SOIR) of 0.42, which ranks higher than only 8% of readings from the past year.
What's more, the stock sports a lofty Schaeffer's Volatility Scorecard (SVS) of 99 out of 100, suggesting that the equity has consistently realized higher-than-expected volatility over the past 12 months.
The SEC Moves to End the $25,000 Day Trading Barrier
For years, this rule kept most traders on the sidelines. Now, the door is opening to a whole new wave of active traders.
Dynamite Day Trading Signals helps you hit the ground running with up 2 options trade alerts per week, built to capture fast-moving opportunities.
ARLINGTON, Va.--(BUSINESS WIRE)--AeroVironment, Inc. (“AV”) (NASDAQ: AVAV) will host an investor day in New York City on Wednesday, July 8, 2026. Management presentations and discussions can be viewed that day during a live webcast starting at 5:30 a.m. PT / 6:30 a.m. MT / 7:30 a.m. CT / 8:30 a.m. ET.
The event will include presentations from Wahid Nawabi, AV’s chairman, president and chief executive officer; Sean Woodward, senior vice president and chief financial officer; Dr. Rob Smith, chief operations officer and other members of the executive management team.
You can access the live webcast at the link below:
https://edge.media-server.com/mmc/p/yj2249s9/
About AV
AeroVironment (“AV”) (NASDAQ: AVAV) is a defense technology leader delivering integrated capabilities across air, land, sea, space, and cyber. The Company develops and deploys autonomous systems, loitering munitions, counter-UAS technologies, space-based platforms, directed energy systems, and cyber and electronic warfare capabilities—built to meet the mission needs of today’s warfighter and tomorrow’s conflicts. At the core of these technologies lies AV_Halo™, a modular, mission-ready suite of AI-powered software tools that empowers warfighters and enables full-battlefield dominance: detect, decide, deliver. With a national manufacturing footprint and a deep innovation pipeline, AV delivers proven systems and future-defining capabilities at speed, scale, and operational relevance. For more information, visit www.avinc.com.
Safe Harbor Statement
Certain statements in this press release may constitute "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations, forecasts, and assumptions that involve risks and uncertainties, which could cause actual results to differ materially. Factors that may cause such differences include, but are not limited to, our ability to perform under existing contracts and obtain new ones; regulatory changes; competitor activities; market growth; product development challenges; and general economic conditions. For a more detailed discussion of these risks, please refer to AeroVironment’s filings with the Securities and Exchange Commission. We undertake no obligation to update forward-looking statements as a result of new information or future events.
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In AeroVironment To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in AeroVironment between June 25, 2025 and March 10, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
[You may also click here for additional information]
New York, New York--(Newsfile Corp. - June 17, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against AeroVironment, Inc. ("AeroVironment" or the "Company") (NASDAQ: AVAV) and reminds investors of the July 27, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.
As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) AeroVironment understated the likelihood that it would imminently face competition from other vendors for the work it performed in connection with the SCAR program and the U.S. Space Force's ongoing efforts to modernize the SCN; (2) accordingly, Defendants overstated AeroVironment's business and financial prospects; and (3) as a result, Defendants' public statements were materially false and misleading at all relevant times.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding AeroVironment's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
To learn more about the AeroVironment class action, go to www.faruqilaw.com/AVAV or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
Follow us for updates on LinkedIn, on X, or on Facebook.
Frequently Asked Questions (FAQ) for Investors Regarding the AeroVironment Securities Class Action Lawsuit:
What is the AeroVironment securities fraud lawsuit about?
The AeroVironment securities fraud lawsuit is a federal securities class action alleging that AeroVironment, Inc. (NASDAQ: AVAV) and its executives made false and misleading statements to investors by concealing that the Company faced imminent competition for its SCAR program contracts and overstating its business and financial prospects. As the truth emerged through a series of disclosures - including a U.S. government stop work order on January 20, 2026, a Space Force announcement that it was reopening the SCAR program on March 2, 2026, and AeroVironment's disclosure of a $151.3 million goodwill impairment and contract termination on March 10, 2026 - AVAV's stock price dropped sharply, causing significant losses for investors.
Who may be eligible to participate in the lawsuit?
Investors who purchased or acquired AeroVironment (AVAV) stock between June 25, 2025 and March 10, 2026 - the Class Period - and suffered financial losses may be eligible to participate in the AeroVironment securities class action. Participation as a class member does not require taking any affirmative legal action; eligible investors may recover losses simply by remaining members of the class. Whistleblowers, former AeroVironment employees, and others with relevant information about the Company's conduct are also encouraged to come forward.
What is a lead plaintiff, and how can I seek appointment?
A lead plaintiff in the AeroVironment class action is a court-appointed investor - typically the one with the largest financial interest in the case - who directs and oversees the litigation on behalf of all class members. Any AeroVironment investor who purchased AVAV stock during the Class Period may move the Court to serve as lead plaintiff through counsel of their choice. The deadline to seek lead plaintiff appointment is July 27, 2026. Importantly, choosing not to seek the lead plaintiff role does not affect an investor's ability to share in any recovery obtained for the class.
What should investors do if they purchased AeroVironment stock during the Class Period?
Investors who purchased AeroVironment (AVAV) stock between June 25, 2025 and March 10, 2026 and suffered losses should contact Faruqi & Faruqi, LLP immediately to discuss their legal rights. The deadline to seek appointment as lead plaintiff in the AeroVironment securities class action is July 27, 2026. To speak directly with securities litigation partner Josh Wilson, call 877-247-4292 or 212-983-9330 (Ext. 1310), or visit www.faruqilaw.com/AVAV for more information.
Why should investors contact Faruqi & Faruqi, LLP?
Faruqi & Faruqi, LLP has represented investors in securities litigation for decades and has recovered hundreds of millions of dollars for shareholders. Investors who purchased AeroVironment securities during the Class Period may contact the firm to discuss their legal rights, potential claims, and the lead plaintiff process at no cost or obligation.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/301714
Source: Faruqi & Faruqi LLP
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
, /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against AeroVironment, Inc. ("AeroVironment" or the "Company") (NASDAQ: AVAV) and certain officers. The class action, filed in the United States District Court for the Eastern District of Virginia, and docketed under 26-cv-01429, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired AeroVironment securities between June 25, 2025 and March 10, 2026, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
If you are an investor who purchased or otherwise acquired AeroVironment securities during the Class Period, you have until July 27, 2026, to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Danielle Peyton at [email protected] or 646-581-9980 (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
[Click here for information about joining the class action]
AeroVironment operates as a defense technology provider delivering integrated capabilities across air, land, sea, space, and cyber.
On May 1, 2025, AeroVironment announced it had completed the acquisition of BlueHalo, LLC ("BlueHalo"), a defense technology firm specializing in advanced engineering products, in an all-stock transaction with an enterprise value of approximately $4.1 billion.
Three years earlier, BlueHalo had been awarded a $1.4 billion contract to deliver BADGER phased array antenna systems (a type of advanced ground-terminal system used to track satellites), to support the United States Space Force's Satellite Communication Augmentation Resource ("SCAR") program. The BADGER would be a bespoke product designed for the United States ("U.S.") Space Force, according to its specifications. This contract value subsequently increased to $1.7 billion.
The SCAR program represents the U.S. Space Force's efforts to modernize antennas used by the Satellite Control Network ("SCN"), which is comprised of 19 fixed antennas across the world and executes tasks such as tracking satellites, transmitting signals, and conducting telemetry, or accessing data from satellites to assess their status and health.
In an April 2023 report, the U.S. Government Accountability Office described the SCN as "aging and difficult to maintain." The U.S. Space Force has described the purpose of the SCAR program as modernizing the aging SCN by introducing phased array antennas to the network that boast newer capabilities, such as the ability to communicate with more than one satellite simultaneously.
During the Class Period, Defendants consistently assured investors that the SCAR program would drive revenue growth for AeroVironment moving forward. Among other items, Defendants stated that the SCAR program represented a "tremendous growth opportunity," that AeroVironment's work pursuant to the contract was "very much on track," that the customer was "asking for more [BADGER systems]," and that the Company stood "ready to build more."
The complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) AeroVironment understated the likelihood that it would imminently face competition from other vendors for the work it performed in connection with the SCAR program and the U.S. Space Force's ongoing efforts to modernize the SCN; (ii) accordingly, Defendants overstated AeroVironment's business and financial prospects; and (iii) as a result, Defendants' public statements were materially false and misleading at all relevant times.
On January 20, 2026, AeroVironment announced that the U.S. government had issued a stop work order on the Company's agreement to deliver BADGER systems to the SCAR program. In the same announcement, AeroVironment stated that the stop work order "allows for the parties to negotiate an amended agreement for the future of the SCAR program" and that "[t]he Company expects to continue to deliver capabilities and products for the SCAR program."
On this news, AeroVironment's stock price fell $61.97 per share, or 15.77%, to close at $330.89 per share on January 20, 2026.
Then, on March 2, 2026, Space News reported that the U.S. Space Force was reopening the SCAR program and "reassessing how to move forward." Space News quoted Colonel Owen Stevens, director of contracting at the Space Rapid Capabilities Office, which supervised SCAR, as stating, "We have been in conversations with the [senior acquisition executive] for a little while now, and we are going to move into a new acquisition strategy for SCAR."
On this news, AeroVironment's stock price fell $43.93 per share, or 17.42%, to close at $208.32 per share on March 2, 2026.
Then, on March 10, 2026, AeroVironment announced its financial results for the third quarter of fiscal year 2026. Among other items, AeroVironment reported a third-quarter operating loss of $179.0 million, compared to an operating loss of $3.1 million for the same period in fiscal year 2025. These financial results reflected the impact of a $151.3 million goodwill impairment in the Company's space division after the stop work order on the Company's BADGER systems built for the SCAR program. AeroVironment also reported that the U.S. Space Force had terminated the Company's contract concerning the SCAR program, and as a result, it would have to "recompete" for the SCAR program.
On this news, AeroVironment's stock price fell $13.84 per share, or 6.24%, to close at $207.73 per share on March 11, 2026.
On March 31, 2026, the U.S. Space Force announced its decision to diversify suppliers and rely on less costly commercial, off-the-shelf solutions in connection with its work to upgrade the SCN, instead of pursuing another single-vendor bespoke solution.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered billions of dollars in damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
LOS ANGELES, June 18, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against AeroVironment, Inc. (“AeroVironment” or “the Company”) (NASDAQ: AVAV) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Investors who purchased the Company’s securities between June 25, 2025 and March 10, 2026, inclusive (the “Class Period”), are encouraged to contact the firm before July 27, 2026.
If you are a shareholder who suffered a loss, click here to participate.
We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at [email protected].
The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.
According to the Complaint, the Company made false and misleading statements to the market. AeroVironment downplayed the threat of competition related to its work with the U.S. Space Force's Satellite Communication Augmentation Resource ("SCAR") program. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about AeroVironment, investors suffered damages.
Join the case to recover your losses.
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
CONTACT:
The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335 [email protected]
Key Dates and Disclosure Events AeroVironment Shareholders Need to Know: From '$1 Billion Franchise' Claims to Contract Termination and $151.3 Million Goodwill Impairment
, /PRNewswire/ -- SueWallSt encourages investors who suffered losses in AeroVironment, Inc. (NASDAQ: AVAV) to contact the firm. Those who purchased AVAV securities between June 25, 2025 and March 10, 2026 may be entitled to recover damages. Find out if you are eligible to recover losses. You may also contact Joseph E. Levi, Esq. at [email protected] or (888) SueWallSt.
AVAV shares fell 15.77% when AeroVironment first announced its agreement with Space Force was paused on January 20, 2026. In March, the stock fell another 17.42% and 6.24% on further alleged successive related disclosures. The window to apply for lead plaintiff closes on July 27, 2026.
June 24, 2025: Fiscal Year Guidance Sets Investor Expectations
AeroVironment issued fiscal year 2026 guidance projecting revenue between $1.9 billion and $2.0 billion. This guidance incorporated projected results from the recently completed $4.1 billion BlueHalo acquisition and set the baseline that investors relied upon throughout the Class Period.
September 9, 2025: Q1 Results Raise the Bar
The Company reiterated its revenue guidance and raised non-GAAP earnings per diluted share expectations to $3.60 to $3.70. Management described BADGER phased array systems as a "key growth driver" for the space segment, the lawsuit contends.
September 30, 2025: Investor Open House Amplifies Confidence
At the Company's Investor Open House, executives characterized the SCAR program as "a $1 billion franchise" and told attendees the customer was "asking for more" BADGER systems. The filing alleges these representations deepened investor reliance on SCAR-driven revenue.
December 9, 2025: Q2 Earnings Call Reaffirms Trajectory
Management described SCAR as a "tremendous growth opportunity" and stated the program was "very much on track," as alleged in the complaint. Defendants conveyed confidence in full-year guidance, tying expected second-half contract awards to the SCAR program.
January 20, 2026: First Corrective Disclosure
AeroVironment disclosed a stop work order on its BADGER delivery agreement. Shares fell $61.97, or 15.77%, to close at $330.89. The complaint alleges the Company's accompanying statement that it "expects to continue to deliver capabilities and products for the SCAR program" continued to mislead investors.
March 2, 2026: Second Corrective Disclosure
Space News reported the U.S. Space Force was "reassessing how to move forward" with SCAR under a new multi-vendor acquisition strategy. Shares fell $43.93, or 17.42%, to $208.32. Raymond James cut its rating from Strong Buy to Underperform.
March 10, 2026: Third Corrective Disclosure
AeroVironment reported a $179.0 million operating loss, a $151.3 million goodwill impairment, and revealed the Space Force had terminated the SCAR contract for convenience. Revenue guidance was lowered to $1.85 billion to $1.95 billion. Shares fell an additional $13.84 on March 11.
Chronology of Material Events
June 24, 2025: Fiscal year revenue guidance of $1.9B to $2.0B issued, incorporating BlueHalo acquisition September 30, 2025: SCAR described as "a $1 billion franchise" at Investor Open House December 9, 2025: SCAR called a "tremendous growth opportunity" on Q2 earnings call January 20, 2026: Stop work order disclosed; stock drops 15.77% March 2, 2026: Space Force reopens SCAR to multi-vendor competition; stock drops 17.42% March 10, 2026: Contract terminated, $151.3M goodwill impairment recorded, guidance cut "Timely disclosure of material developments is fundamental to fair and efficient markets. The timeline in this case raises questions about when these competitive risks became apparent internally versus when they were communicated to investors." -- Joseph E. Levi, Esq.
Submit your claim before the deadline or call (888) SueWallSt.
ABOUT THE FIRM -- For over two decades, SueWallSt has represented shareholders in securities class actions. Ranked in ISS Top 50 for seven consecutive years. Those wishing to serve as lead plaintiff must act by July 27, 2026.
Frequently Asked Questions About the AVAV Lawsuit
Q: When did AeroVironment allegedly mislead investors? A: The class period runs from June 25, 2025 to March 10, 2026. The alleged fraud was revealed through three corrective disclosures on January 20, March 2, and March 10, 2026, causing cumulative stock declines of approximately $185 per share.
Q: How much did AVAV stock drop? A: Shares fell approximately 15.77% following the first alleged disclosure event on January 20, 2026. The stock sank an addiitonal 17.42% on March 2, 2026, and 6.24% on March 11, 2026, following the next two disclosure events.
Q: What do AVAV investors need to do right now? A: Gather brokerage records including purchase dates, share quantities, and prices paid. Contact SueWallSt for a free, no-obligation evaluation at [email protected] or (888) SueWallSt. No immediate action is required to remain eligible as a class member.
Q: What is a lead plaintiff and why does it matter? A: A lead plaintiff is the investor appointed by the court to represent the entire class. Lead plaintiffs are typically investors with the largest documented losses. Being appointed does not increase individual recovery but gives direct oversight of how the case is run.
Q: What if I already sold my AVAV shares -- can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold them. Investors who bought during the class period and sold at a loss may still participate.
Q: What does it cost me to participate? A: Nothing. Securities class actions are handled on a pure contingency basis. No upfront fees, no retainer, no out-of-pocket costs.
Q: What court was the AVAV class action filed in? A: The case was filed in the United States District Court for the Eastern District of Virginia, Alexandria Division, governed by the Private Securities Litigation Reform Act of 1995.
CONTACT:
SueWallSt
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
[email protected]
Tel: (888) SueWallSt
Fax: (212) 363-7171
, /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against AeroVironment, Inc. ("AeroVironment" or the "Company") (NASDAQ: AVAV).
IF YOU SUFFERED A LOSS ON YOUR AEROVIRONMENT INVESTMENTS, CLICK HERE BEFORE JULY 27, 2026 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT
What Is The Lawsuit About?
The complaint filed alleges that, between June 25, 2025 and March 10, 2026, Defendants failed to disclose to investors that: (1) AeroVironment understated the likelihood that it would imminently face competition from other vendors for the work it performed in connection with the SCAR program and the U.S. Space Force's ongoing efforts to modernize the SCN; (2) accordingly, Defendants overstated AeroVironment's business and financial prospects; and (3) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.
Contact Us To Participate or Learn More:
If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us.
Charles Linehan, Esq.,
Glancy Prongay Wolke & Rotter LLP,
1925 Century Park East, Suite 2100,
Los Angeles California 90067
Email: [email protected]
Telephone: 310-201-9150 (Toll-Free: 888-773-9224)
Visit our website at www.glancylaw.com.
Follow us for updates on LinkedIn, Twitter, or Facebook.
If you inquire by email, please include your mailing address, telephone number and number of shares purchased.
To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contact Us:
Glancy Prongay Wolke & Rotter LLP,
1925 Century Park East, Suite 2100,
Los Angeles, CA 90067
Charles Linehan
Email: [email protected]
Telephone: 310-201-9150
Toll-Free: 888-773-9224
Visit our website at: www.glancylaw.com.
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of AeroVironment, Inc. (NASDAQ: AVAV) between June 25, 2025 and March 10, 2026, inclusive (the “Class Period”), of the important July 27, 2026 lead plaintiff deadline.
SO WHAT: If you purchased AeroVironment securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the AeroVironment class action, go to https://rosenlegal.com/cases/aerovironment-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 27, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) AeroVironment understated the likelihood that it would imminently face competition from other vendors for the work it performed in connection with the U.S. Space Force’s Satellite Communication Augmentation Resources (“SCAR”) program and the U.S. Space Force’s ongoing efforts to modernize the Satellite Control Network (“SCN”); (2) accordingly, defendants overstated AeroVironment’s business and financial prospects; and (3) as a result, defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the AeroVironment class action, go to https://rosenlegal.com/cases/aerovironment-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
-------------------------------
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827 [email protected]
www.rosenlegal.com
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Aerovironment (AVAV) To Contact Him Directly To Discuss Their Options
If you purchased or acquired AeroVironment securities between June 25, 2025 and March 10, 2026 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Melissa Fortunato directly at (212) 355-4648.
Click here to participate in the action.
NEW YORK, June 18, 2026 (GLOBE NEWSWIRE) --
What’s Happening?
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Aerovironment, Inc. (“Aerovironment” or the “Company”) (NASDAQ:AVAV) in the United States District Court for the Eastern District of Virginia on behalf of all persons and entities who purchased or otherwise acquired AeroVironment securities between June 25, 2025 and March 10, 2026, both dates inclusive (the “Class Period”).Investors have until July 27, 2026 to apply to the Court to be appointed as lead plaintiff in the lawsuit. What are the Allegation Details?
The lawsuit alleges that Defendants made false and misleading statements and/or failed to disclose material adverse facts by understating the likelihood that AeroVironment would imminently face competition from other vendors for the work it performed in connection with the Satellite Communication Augmentation Resource program and the U.S. Space Force’s ongoing efforts to modernize the Satellite Control Network.On January 20, 2026, AeroVironment announced that the U.S. government had issued a stop work order on the Company’s agreement to deliver BADGER systems to the SCAR program. On this news, AeroVironment's stock price fell $61.97 per share, or over 15%, to close at $330.89 per share on January 20, 2026.Then, on March 10, 2026, AeroVironment announced disappointing financial results for the third quarter of fiscal year 2026. These financial results reflected the impact of a $151.3 million goodwill impairment in the Company’s space division after the stop work order on the Company’s BADGER systems built for the SCAR program. AeroVironment also reported that the U.S. Space Force had terminated the Company’s contract concerning the SCAR program, and as a result, it would have to “recompete” for the SCAR program. On this news, AeroVironment’s stock price fell $13.84 per share, or 6.24%, to close at $207.73 per share on March 11, 2026. What are my Next Steps?
If you purchased or otherwise acquired Aerovironment shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at [email protected], telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you. About Bragar Eagel & Squire, P.C.:
Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, South Carolina, and California. The firm represents individual and institutional investors in securities,
derivative, and commercial litigation as well as individuals in consumer protection and data privacy litigation. The firm has a nationwide practice and routinely handles cases in both federal and state courts. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.
Follow us for updates on LinkedIn and Facebook, and keep up with other news by following Brandon Walker, Esq. on LinkedIn.
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of AeroVironment, Inc. (NASDAQ: AVAV) between June 25, 2025 and March 10, 2026, inclusive (the "Class Period"), of the important July 27, 2026 lead plaintiff deadline.
So What: If you purchased AeroVironment securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
What to do next: To join the AeroVironment class action, go to https://rosenlegal.com/cases/aerovironment-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 27, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
Details of the case: According to the lawsuit, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) AeroVironment understated the likelihood that it would imminently face competition from other vendors for the work it performed in connection with the U.S. Space Force's Satellite Communication Augmentation Resources ("SCAR") program and the U.S. Space Force's ongoing efforts to modernize the Satellite Control Network ("SCN"); (2) accordingly, defendants overstated AeroVironment's business and financial prospects; and (3) as a result, defendants' public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the AeroVironment class action, go to https://rosenlegal.com/cases/aerovironment-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com
AeroVironment (AVAV - Free Report) closed at $169.61 in the latest trading session, marking a +1.5% move from the prior day. The stock's change was more than the S&P 500's daily gain of 1.09%. Meanwhile, the Dow gained 0.14%, and the Nasdaq, a tech-heavy index, added 1.91%.
Shares of the maker of unmanned aircrafts have appreciated by 1.98% over the course of the past month, underperforming the Aerospace sector's gain of 10.21%, and outperforming the S&P 500's gain of 0.29%.
Investors will be eagerly watching for the performance of AeroVironment in its upcoming earnings disclosure. The company's earnings report is set to be unveiled on June 29, 2026. The company's upcoming EPS is projected at $1.53, signifying a 4.97% drop compared to the same quarter of the previous year. In the meantime, our current consensus estimate forecasts the revenue to be $563.14 million, indicating a 104.74% growth compared to the corresponding quarter of the prior year.
In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $2.94 per share and a revenue of $1.9 billion, indicating changes of -10.37% and +131.33%, respectively, from the former year.
Any recent changes to analyst estimates for AeroVironment should also be noted by investors. Recent revisions tend to reflect the latest near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Our research shows that these estimate changes are directly correlated with near-term stock prices. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed an unchanged state. AeroVironment presently features a Zacks Rank of #3 (Hold).
In the context of valuation, AeroVironment is at present trading with a Forward P/E ratio of 44.75. Its industry sports an average Forward P/E of 39.5, so one might conclude that AeroVironment is trading at a premium comparatively.
It is also worth noting that AVAV currently has a PEG ratio of 2.29. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. Aerospace - Defense Equipment stocks are, on average, holding a PEG ratio of 2.24 based on yesterday's closing prices.
The Aerospace - Defense Equipment industry is part of the Aerospace sector. This industry currently has a Zacks Industry Rank of 73, which puts it in the top 30% of all 250+ industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions.
, /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of AeroVironment, Inc. (NASDAQ: AVAV) securities between June 25, 2025 and March 10, 2026, inclusive (the "Class Period"), have until Monday, July 27, 2026 to seek appointment as lead plaintiff of the AeroVironment class action lawsuit. Captioned Norrell v. AeroVironment, Inc., No. 26-cv-01429 (E.D. Va.), the AeroVironment class action lawsuit charges AeroVironment and certain of AeroVironment's top current and former executive officers with violations of the Securities Exchange Act of 1934.
If you suffered substantial losses and wish to serve as lead plaintiff of the AeroVironment class action lawsuit, please provide your information here:
You can also contact attorneys Ken Dolitsky or Michael Albert of Robbins Geller by calling 800/851-7783 or via e-mail at [email protected].
CASE ALLEGATIONS: AeroVironment designs, develops, produces, delivers, and supports a portfolio of robotic systems and related services for government agencies and businesses. The AeroVironment class action lawsuit alleges on May 1, 2025, AeroVironment announced it had completed the acquisition of BlueHalo, LLC, which had previously been awarded a contract to support the U.S. Space Force's Satellite Communication Augmentation Resource ("SCAR") program. The SCAR program represents the U.S. Space Force's efforts to modernize antennas used by the Satellite Control Network ("SCN"), which is comprised of 19 fixed antennas across the world and executes tasks such as tracking satellites, transmitting signals, and conducting telemetry, or accessing data from satellites to assess their status and health, according to the complaint.
The AeroVironment class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) AeroVironment understated the likelihood that it would imminently face competition from other vendors for the work it performed in connection with the SCAR program and the U.S. Space Force's ongoing efforts to modernize the SCN; and (ii) accordingly, defendants overstated AeroVironment's business and financial prospects.
The AeroVironment class action lawsuit further alleges that on January 20, 2026, AeroVironment announced that the U.S. government had issued a stop work order on AeroVironment's agreement to deliver BADGER systems to the SCAR program. In the same announcement, AeroVironment allegedly stated that the stop work order "allows for the parties to negotiate an amended agreement for the future of the SCAR program" and that "[t]he Company expects to continue to deliver capabilities and products for the SCAR program." On this news, the price of AeroVironment stock fell nearly 16%, according to the complaint.
Then, on March 2, 2026, SpaceNews allegedly reported that the U.S. Space Force was reopening the SCAR program and "reassessing how to move forward." Space News quoted Colonel Owen Stevens, director of contracting at the Space Rapid Capabilities Office, which supervised SCAR, as stating: "We have been in conversations with the SAE [senior acquisition executive] for a little while now, and we are going to move into a new acquisition strategy for SCAR," the complaint alleges. On this news, the price of AeroVironment stock fell more than 17%, according to the complaint.
Finally, on March 10, 2026, the complaint alleges that AeroVironment announced its financial results for the third quarter of fiscal year 2026. Among other items, AeroVironment allegedly reported a third-quarter operating loss of $179.0 million, compared to an operating loss of $3.1 million for the same period in fiscal year 2025. These financial results reflected the impact of a $151.3 million goodwill impairment in AeroVironment's space division after the stop work order on AeroVironment's BADGER systems built for the SCAR program, according to the AeroVironment class action lawsuit. AeroVironment also allegedly reported that the U.S. Space Force had terminated AeroVironment's contract concerning the SCAR program, and as a result, it would have to "recompete" for the SCAR program. On this news, the price of AeroVironment stock fell more than 6%, the complaint alleges.
THE LEAD PLAINTIFF PROCESS: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased or acquired AeroVironment securities during the Class Period to seek appointment as lead plaintiff in the AeroVironment class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other class members in directing the AeroVironment class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the AeroVironment class action lawsuit. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the AeroVironment class action lawsuit.
ABOUT ROBBINS GELLER: Robbins Geller Rudman & Dowd LLP is one of the world's leading law firms representing investors in securities fraud and shareholder rights litigation. Our Firm ranked #1 on the most recent ISS Securities Class Action Services Top 50 Report, recovering more than $916 million for investors in 2025. This marks our fourth #1 ranking in the past five years. And in those five years alone, Robbins Geller recovered $8.4 billion for investors – $3.4 billion more than any other law firm. With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs' firms in the world, and the Firm's attorneys have obtained many of the largest securities class action recoveries in history, including the largest ever – $7.2 billion – in In re Enron Corp. Sec. Litig. Please visit the following page for more information:
NEW YORK, June 19, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of AeroVironment, Inc. (NASDAQ: AVAV).
Shareholders who purchased shares of AVAV during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.
ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) AeroVironment understated the likelihood that it would imminently face competition from other vendors for the work it performed in connection with the U.S. Space Force’s Satellite Communication Augmentation Resource program and the U.S. Space Force’s ongoing efforts to modernize the Satellite Control Network; (ii) accordingly, defendants overstated AeroVironment’s business and financial prospects; and (iii) as a result, defendants’ public statements were materially false and misleading at all relevant times.
DEADLINE: July 27, 2026 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/aerovironment-loss-submission-form-2/?id=188977&from=3
NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of AVAV during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is July 27, 2026. There is no cost or obligation to you to participate in this case.
WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903
New York, New York--(Newsfile Corp. - June 19, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of AeroVironment, Inc. (NASDAQ: AVAV) between June 25, 2025 and March 10, 2026, inclusive (the "Class Period"), of the important July 27, 2026 lead plaintiff deadline.
SO WHAT: If you purchased AeroVironment securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the AeroVironment class action, go to https://rosenlegal.com/cases/aerovironment-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 27, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) AeroVironment understated the likelihood that it would imminently face competition from other vendors for the work it performed in connection with the U.S. Space Force's Satellite Communication Augmentation Resources ("SCAR") program and the U.S. Space Force's ongoing efforts to modernize the Satellite Control Network ("SCN"); (2) accordingly, defendants overstated AeroVironment's business and financial prospects; and (3) as a result, defendants' public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the AeroVironment class action, go to https://rosenlegal.com/cases/aerovironment-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
-------------------------------
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/302177
Source: The Rosen Law Firm PA
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
NEW YORK, June 19, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against AeroVironment, Inc. (NASDAQ: AVAV) and certain of its officers.
This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired AeroVironment securities between June 25, 2025 and March 10, 2026, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: bgandg.com/AVAV.
AeroVironment Case Details
The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operations, and prospects. Specifically, the Complaint alleges that Defendants made false and/or misleading statements and/or failed to disclose that:
(1) AeroVironment understated the likelihood that it would imminently face competition from other vendors for the work it performed in connection with the SCAR program and the U.S. Space Force’s ongoing efforts to modernize the SCN;
(2) accordingly, Defendants overstated AeroVironment’s business and financial prospects; and
(3) as a result, Defendants’ public statements were materially false and misleading at all relevant times.
What's Next for AeroVironment Investors?
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm’s site: bgandg.com/AVAV. or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911. If you suffered a loss in AeroVironment you have until July 27, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.
No Cost to AeroVironment Investors
We, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman, LLC for AeroVironment Securities Class Action?
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com
"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.
Follow us for updates on LinkedIn, X, Facebook, or Instagram.
Contact Info
Peretz Bronstein, Esq. or Nathan Miller
Bronstein, Gewirtz & Grossman, LLC
917-590-0911 | [email protected]
Attorney advertising.
Prior results do not guarantee similar outcomes.
New York, New York--(Newsfile Corp. - June 19, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against AeroVironment, Inc. (NASDAQ: AVAV) and certain of its officers.
This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired AeroVironment securities between June 25, 2025 and March 10, 2026, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/AVAV.
AeroVironment Case Details
The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects. Specifically, the Complaint alleges that Defendants made false and/or misleading statements and/or failed to disclose that:
AeroVironment understated the likelihood that it would imminently face competition from other vendors for the work it performed in connection with the SCAR program and the U.S. Space Force's ongoing efforts to modernize the SCN; accordingly, Defendants overstated AeroVironment's business and financial prospects; and as a result, Defendants' public statements were materially false and misleading at all relevant times.What's Next for AeroVironment Investors?
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm's site: bgandg.com/AVAV, or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911. If you suffered a loss in AeroVironment you have until July 27, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.
No Cost to AeroVironment Investors
We, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman, LLC for AeroVironment Securities Class Action?
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com
"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.
Follow us for updates on LinkedIn, X, Facebook, or Instagram.
Attorney advertising.
Prior results do not guarantee similar outcomes.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/299076
Source: Bronstein, Gewirtz & Grossman, LLC
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In AeroVironment To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in AeroVironment between June 25, 2025 and March 10, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
[You may also click here for additional information]
New York, New York--(Newsfile Corp. - June 20, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against AeroVironment, Inc. ("AeroVironment" or the "Company") (NASDAQ: AVAV) and reminds investors of the July 27, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.
As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) AeroVironment understated the likelihood that it would imminently face competition from other vendors for the work it performed in connection with the SCAR program and the U.S. Space Force's ongoing efforts to modernize the SCN; (2) accordingly, Defendants overstated AeroVironment's business and financial prospects; and (3) as a result, Defendants' public statements were materially false and misleading at all relevant times.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding AeroVironment's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
To learn more about the AeroVironment class action, go to www.faruqilaw.com/AVAV or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
Follow us for updates on LinkedIn, on X, or on Facebook.
Frequently Asked Questions (FAQ) for Investors Regarding the AeroVironment Securities Class Action Lawsuit:
What is the AeroVironment securities fraud lawsuit about?
The AeroVironment securities fraud lawsuit is a federal securities class action alleging that AeroVironment, Inc. (NASDAQ: AVAV) and its executives made false and misleading statements to investors by concealing that the Company faced imminent competition for its SCAR program contracts and overstating its business and financial prospects. As the truth emerged through a series of disclosures - including a U.S. government stop work order on January 20, 2026, a Space Force announcement that it was reopening the SCAR program on March 2, 2026, and AeroVironment's disclosure of a $151.3 million goodwill impairment and contract termination on March 10, 2026 - AVAV's stock price dropped sharply, causing significant losses for investors.
Who may be eligible to participate in the lawsuit?
Investors who purchased or acquired AeroVironment (AVAV) stock between June 25, 2025 and March 10, 2026 - the Class Period - and suffered financial losses may be eligible to participate in the AeroVironment securities class action. Participation as a class member does not require taking any affirmative legal action; eligible investors may recover losses simply by remaining members of the class. Whistleblowers, former AeroVironment employees, and others with relevant information about the Company's conduct are also encouraged to come forward.
What is a lead plaintiff, and how can I seek appointment?
A lead plaintiff in the AeroVironment class action is a court-appointed investor - typically the one with the largest financial interest in the case - who directs and oversees the litigation on behalf of all class members. Any AeroVironment investor who purchased AVAV stock during the Class Period may move the Court to serve as lead plaintiff through counsel of their choice. The deadline to seek lead plaintiff appointment is July 27, 2026. Importantly, choosing not to seek the lead plaintiff role does not affect an investor's ability to share in any recovery obtained for the class.
What should investors do if they purchased AeroVironment stock during the Class Period?
Investors who purchased AeroVironment (AVAV) stock between June 25, 2025 and March 10, 2026 and suffered losses should contact Faruqi & Faruqi, LLP immediately to discuss their legal rights. The deadline to seek appointment as lead plaintiff in the AeroVironment securities class action is July 27, 2026. To speak directly with securities litigation partner Josh Wilson, call 877-247-4292 or 212-983-9330 (Ext. 1310), or visit www.faruqilaw.com/AVAV for more information.
Why should investors contact Faruqi & Faruqi, LLP?
Faruqi & Faruqi, LLP has represented investors in securities litigation for decades and has recovered hundreds of millions of dollars for shareholders. Investors who purchased AeroVironment securities during the Class Period may contact the firm to discuss their legal rights, potential claims, and the lead plaintiff process at no cost or obligation.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/301758
Source: Faruqi & Faruqi LLP
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
On a recent episode of the Catalyst with Shayle Kann podcast themed around the “electric supercycle,” investor Andy Lubershein floated a provocative idea: military drones, not electric vehicles, may be the unlikely catalyst for next-generation battery technology. “Defense historically has been a sector that has a high willingness to pay for performance,” Lubershein argued lithium-ion cells are “kind of good enough from a range standpoint” for cars. Pay four times the price for triple the energy density? Carmakers will pass. The Pentagon will not.
Why Drones Could Crack the Battery Funding Problem Lubershein’s framing is a venture capital question applied to chemistry: “The question is always like, who’s going to pay for the first 1,000, and then how are you going to scale it up?” Drones are already shipping “in the hundreds of millions, probably getting towards the billions.” Host Shayle Kann noted the government is moving: an ARPA-E program called “1K” targeted a 1,000 watt-hour per kilogram cell, roughly 3x today’s best, and a DOD initiative aiming for 2,000 watt-hour per kilogram batteries, driven predominantly by drone applications. The spillover thesis is the payoff. “If you had a 2,000 watt-hour per kilogram battery and then you applied that into, for example, heavy-duty transportation, complete game changer,” Lubershein said.
The macro backdrop fits. The FY2027 Department of War budget request includes $54.0 billion for autonomous and remotely operated systems, with $39.2 billion tied to a multi-year Drone Dominance mandatory funding request, plus $20.6 billion for one-way attack munitions, counter-small-UAS, and related programs. The three names below make drone platforms, not breakthrough cells, so they benefit indirectly through stronger procurement budgets and pull-through demand for any battery the DoD ultimately funds.
AeroVironment: The Lower-Risk Anchor AeroVironment (NASDAQ:AVAV | AVAV Price Prediction) is the established play. Q3 FY2026 revenue hit $408.05M, up 143.4% year over year, though it missed consensus by 14.21% after a $151.31M goodwill impairment on the BADGER SCAR stop-work order. Funded backlog hit a record $1.10B with a 1.6x book-to-bill, and CEO Wahid Nawabi said “demand for our unique solutions remains robust” in the filing.
At $169.61, the stock is down 29.88% year to date. Our proprietary 24/7 Wall St. price target sits at about $236 (roughly 39% upside) with Street consensus near $310 and a 6/10/3 strong-buy/buy/hold split. Forward EPS of about $3.16 makes it the only profitable name in the trio.
Ondas: Higher Torque, Higher Beta Ondas Holdings (NASDAQ:ONDS) posted Q1 2026 revenue of $50.12M, up 1,079.8% year over year, with pro forma backlog jumping to $457M from $68.3M at year-end 2025. CEO Eric Brock cited “powerful demand tailwinds, particularly across counter-UAS and defense robotics markets” and raised the FY2026 target to at least $390M. The Mistral acquisition brought a $982M IDIQ program with the U.S. Army for loitering munitions.
Beta sits at 2.622. Shares trade at $9.27, up 498.06% over one year, against a model target of about $13 (roughly 41% upside). Adjusted EBITDA remains a loss of $10.88M, with profitability not expected until Q1 2028.
Red Cat: The Speculative Sleeve Red Cat Holdings (NASDAQ:RCAT) delivered Q1 FY2026 revenue of $15.47M, up 849.3% year over year, with gross margin swinging to 12.7% from negative 52.1%. Operating cash burn was $31.95M. CEO Jeff Thompson flagged “budget allocations of up to $74 billion for UAV and USV procurement” for 2027 and the short-to-medium term revenue target of $150M to $180M.
At $11.44, Wall Street’s average price target sits at about $22 with lower model confidence, and forward EPS is about negative $0.71.
Which Wins if the Battery Push Materializes? If the Lubershein-Kann thesis plays out, every DoD dollar chasing higher energy density flows through drone platform demand. AeroVironment is the lower-risk anchor: real backlog, real non-GAAP earnings, and the broadest portfolio. Ondas offers higher torque for investors comfortable with a 2.6 beta and acquisition-driven growth. Red Cat is the speculative sleeve for those willing to underwrite execution risk against a large potential payoff. The battery breakthrough may be years away, but procurement budgets are funding the runway today.
New York, New York--(Newsfile Corp. - June 20, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of AeroVironment, Inc. (NASDAQ: AVAV) between June 25, 2025 and March 10, 2026, inclusive (the "Class Period"), of the important July 27, 2026 lead plaintiff deadline.
SO WHAT: If you purchased AeroVironment securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the AeroVironment class action, go to https://rosenlegal.com/cases/aerovironment-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 27, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) AeroVironment understated the likelihood that it would imminently face competition from other vendors for the work it performed in connection with the U.S. Space Force's Satellite Communication Augmentation Resources ("SCAR") program and the U.S. Space Force's ongoing efforts to modernize the Satellite Control Network ("SCN"); (2) accordingly, defendants overstated AeroVironment's business and financial prospects; and (3) as a result, defendants' public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the AeroVironment class action, go to https://rosenlegal.com/cases/aerovironment-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
-------------------------------
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/302211
Source: The Rosen Law Firm PA
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.